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ABSTRACT
THE ELECTRICAL PROPERTIES OF HUMAN TISSUE FOR THE DIAGNOSIS
AND TREATMENT OF MELANOMA SKIN CANCER

By
Glenn Cameron Stante

This thesis discusses the research, experimental methods, and data gathered for
the investigation of a novel method for the diagnosis of melanoma skin cancer. First, a
background about human skin tissue is presented. Then, a detailed description of
melanoma along with current diagnosis techniques and treatment options are presented.
In the experimental methods, the electrical properties of several types of tissue were
analyzed, the purpose of which was to discover if a tissue type can be distinguished by its
electrical properties alone. This would allow for the diagnosis of melanoma to be done
by examining the electrical properties of the suspected tumor and comparing the results
to known values of healthy and cancerous skin. After analyzing the data, it was
concluded that tissue types can be identified by their electrical properties and it may be
possible to diagnose melanoma through this method. Finally, the possibility of using a
similar technology and radiofrequency tissue ablation to treat melanoma is presented.
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Introduction
Thesis Objective
The objective of this thesis is to create, test, and evaluate a new method for the
diagnosis of skin cancer. This new diagnosis method utilizes bipolar electrodes and an
analysis of the electrical properties of the skin to differentiate between healthy and
cancerous tissue. This thesis includes the initial steps in developing this new diagnostic
method. In order to complete the objective of examining the electrical properties of skin,
a fixture was designed and fabricated and the electrical properties of skin analogues were
measured. The purpose of this data is to determine if there is a statistical difference
between healthy and cancerous tissue.
The objective of this thesis is also to discuss future steps that can be taken to
extend this technology to include a method of skin cancer treatment using radio
frequency tissue ablation. The technology to ablate cancerous tissue is similar to the
diagnosis technology discussed in this thesis. To accomplish this objective, previous uses
of tissue ablation to treat cancer were researched and are discussed.

Purpose of Thesis
The purposes of this thesis are to: 1) present information on skin cancer, 2)
identify a new method of diagnosing skin cancer, 3) collect preliminary data on such a
method of skin cancer diagnosis, 4) review previous research in the area of radio
frequency tissue ablation to treat cancer, and 5) make conclusions on these new methods
of diagnosing and treating skin cancer. This thesis also outlines the next steps that need
to be taken to further develop this technology.
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Background
The Skin
In order to understand skin cancer, it will be helpful first to have an understanding
of skin and the different layers of tissue that comprise it. The skin is the largest organ in
the human body [1]. The surface area of skin is approximately 22 square feet and weighs
between 10 and 11 pounds, depending on body size [2]. The primary functions of skin
are to [3]:
•

protect the body from damage and infection

•

excrete salts, wastes, and water to help the body maintain homeostasis

•

sense touch, pain, pressure, and temperature

•

regulate body temperature

•

store fat

•

synthesize vitamin D which allows the small intestines to absorb calcium and
phosphorus into the bloodstream

The skin consists of three main layers of tissue (see Figure 1 [4]). From the most
external to internal, these layers are the: epidermis, dermis, and subcutis. The epidermis
is approximately one hundredths of an inch thick. The thickness of the dermis varies
between 0.012 inches to 0.12 inches, depending on the area of the body. The thickness of
the subcutis varies greatly from person to person depending on the amount of body fat.
The epidermis will be the main concern of the experiments discussed later in this thesis,
so the structure of the epidermis will be focused on.
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Figure 1 – Skin Cross Section
Section

Figure 1 – Skin Cross Section
A cross section showing the different layers of skin
The purpose of the epidermis is to protect the deeper layers of skin [5]. The main
type of cells in the epidermis is keratinocytes. Nine out of ten cells in the epidermis are
keratinocytes [3]. Keratinocytes produce a protein called keratin, which contributes to
the skin's ability to protect the body by making the skin hydrophobic [5]. The epidermis
is separated into 5 layers of cells. These layers, from the most external to internal, are
the: stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and
stratum basale [3]. The stratum corneum is composed of dead keratinocytes that
originated in the stratum basale and have migrated outwards. The stratum basale is the
deepest layer of the epidermis. This layer contains cells that continuously divide to
produce new keratinocytes. When a cell in the stratum basale layer divides, one cell stays
in the basal layer and retains the ability to divide. The other cell loses the ability to
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divide and moves into a higher layer of the epidermis (see Figure 2 [6]). The rate of
division at the stratum basale is the same as the rate at which dead cells are shed off of
the body in the stratum corneum. This allows the number of cells in each layer to stay
constant [6]. The other layers of the epidermis do not perform specific functions but are
simply a progression of skin cells from internal to outer layers.

Figure 2 – Normal Skin Growth
The migration of skin cells from the basal layer
The stratum basale layer also contains melanocytes. Melanocytes produce a
protein called melanin [7]. The purpose of melanin is to protect the cells of the epidermis
from ultraviolet light [3]. The importance of protecting skin cells from UV light is
discussed in the “What Causes Melanoma” section. Melanin is also the source of
pigmentation of the skin [2]. When skin is exposed to ultraviolet light, the melanocytes
produce more melanin, which causes the skin to darken [1].
The next layer of tissue in skin is the dermis. The dermis is thicker than the
epidermis. The purpose of the dermis is to contain hair follicles, sweat glands, nerves,
and blood vessels. The dermis is held together by a layer of collagen [5].
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The deepest layer of the skin is the subcutis. The subcutis consists of a network of fat
cells and collagen. The purpose of the subcutis is to conserve heat and act as a shock
absorber to prevent injury to the deeper structures of the body [5].
Now that a basic understanding of the anatomy of skin has been established, a
discussion about cancer and skin cancer specifically, may take place.

Cancer
This section will discuss a generalized definition of cancer, the cause of cancer,
and the types of cancer. A specific discussion about skin cancer will take place in the
next section, “Skin Cancer.”
Cancer is a term used to describe a disease in which abnormal cells divide and
multiply without control and are able to invade other parts of the body [8]. Instead of
dying after a normal life cycle, cancer cells outlive normal cells and continue to form
other abnormal cells. Cancer develops due to damage to the DNA of the cell that controls
normal growth and division [5]. A change to a cell's DNA is called a mutation.
Mutations occur for a variety of reasons that will be discussed later. The extra cells that
form due to the mutation form a mass called a tumor. A tumor can be either benign or
malignant. Benign tumors are not cancerous, meaning the cells do not spread to other
parts of the body. Tumors that are malignant are cancerous and can invade other parts of
the body. When cancer cells from a tumor invade other areas of the body, it is called
metastasis [6]. If the spread of cancer cells are not controlled, death can result from the
cancer cells interfering with the normal functions of the tissues of the body [9].
There are five types of cancer: carcinoma, sarcoma, leukemia, lymphoma, and
central nervous system cancers. Carcinomas begin in the skin or in the epithelial cells
5

that cover internal organs. Sarcomas begin in the bone, cartilage, fat, muscle, blood
vessels, or other connective or supportive tissue. Leukemia begins in the bone marrow.
Lymphoma cancers begin in the cells that make up the immune system. Central nervous
system cancers begin the brain or spinal cord [4].
Tumors are structurally different from normal tissue. Because the cells that
compose tumors are caused by an over proliferation of cells, the cell density of tumors is
higher than normal tissue [10]. This causes tumors to have different electrical properties
than normal tissue, which is discussed further in the “Electrical Properties of Skin”
section and will become important when trying to diagnose cancerous tissues using
electrical properties.

Skin Cancer
Now that the structure and functions of skin have been discussed and a basic
understanding of cancer has been established, the different cancers that are associated
with the skin can be discussed. The three most common types of skin cancer are: basal
cell carcinoma, squamous cell carcinoma, and melanoma. Because melanoma is the
deadliest type of skin cancer, it will be discussed in depth. For the remainder of this
thesis, when the term “skin cancer” is mentioned, it is assumed that this term is referring
to melanoma, unless otherwise specified. The following sections will discuss the
physiology, causes, risk factors, and prognosis of melanoma skin cancer.
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Melanoma
Introduction to Melanoma
Melanoma is a carcinoma of the skin and is the most deadly type of skin cancer.
Melanoma is more likely than other types of skin cancer to become malignant and spread
to other areas of the body [9], often to the lungs and liver [11]. Each year, approximately
53,600 people are diagnosed with melanoma. In Western countries, the number of people
diagnosed with melanoma is increasing each year. In the United States for example, the
percentage to people diagnosed with melanoma has doubled in the last 30 years [12].

What is Melanoma?
Melanoma is a type of cancer that originates in the melanocytes of the epidermis
[12]. Melanoma often begins as non-cancerous benign tumors [7]. These non-cancerous
tumors are called, “nevi,” or their common name, “moles.” Nevi are clusters of
melanocytes and surrounding connective tissue [12]. Most nevi are harmless but some
can develop into cancerous melanoma through mutations in the DNA of the melanocytes
[7]. Once the melanocytes become malignant, melanoma has developed.
Melanoma is characterized by unchecked growth and replication of melanocytes
(see Figure 3 [6]) [12]. Melanoma tumors are often brown or black in color because the
extra melanocytes continue to produce melanin, darkening the area around the melanoma
[7]. The most common area for melanoma to develop is on the skin. This type of
melanoma is called cutaneous melanoma. Melanoma can also develop in other tissues
where melanocytes are present, such as in the eye, the meninges, the digestive tract, or
the lymph nodes [12]. These less common types of melanoma will not be discussed
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further in this thesis. When the tern “melanoma” is used, it is referring to cutaneous
melanoma.

Figure 3 - Beginning of Cancerous Growth
The progression of Melanoma
As melanoma progresses from a cancerous nevus to later stages, it invades the
deeper layers of tissue below the epidermis (see the “Staging Melanoma” section).
However, it does not do so in a uniform manner. Melanoma invades the dermis and
subcutis and dermis with finger-like projections (see figure 4 [12]). This non-uniformity
will become important later on when discussing the possibility of the diagnosis of
melanoma via electrical properties, which is the main purpose of this thesis.
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Figure 4 - Cancer Histology
4 slides showing the progression of melanoma
What Causes Melanoma?
Melanoma is caused by DNA mutation in the melanocytes. These mutations are
usually caused by exposure to ultraviolet light, which create an error in the DNA
sequence but may also be caused by inherited genetic mutations or exposure to dangerous
chemicals.
When genes that control the normal growth and replication of melanocytes are
damaged, melanoma can result. Some of the specific gene mutations that result in
melanoma have been identified. One non-inherited gene mutation that is found in
melanoma is to the BRAF gene. The BRAF gene is responsible for making a protein
called BRA-F, which is involved in cell replication. When the gene becomes damaged,
the cell may no longer replicate correctly. A mutation to the BRAF gene has been found
in 70% of all melanoma cancers [7].
One type of inherited gene mutation (meaning it is not caused by exposure to
ultraviolet light) that may cause melanoma is the CDKN2A (also known as p16) gene and
the CDK4 gene. These genes are responsible for controlling the growth of melanocytes.
9

Mutations to these genes cause cell overgrowth which can lead to cancer [7]. Since these
gene mutations can be inherited, they may be the reason why people with a family history
of melanoma are more likely to develop melanoma themselves.

Where on the Body does Melanoma Occur?
Melanoma can occur anywhere on the skin. However, there are areas that are
more likely than others to develop melanoma [12]. Males are more likely to develop
melanoma on the trunk (the area between the shoulders and the hips). Women are most
likely to develop melanoma on the legs. The neck and face are other common areas for
the development of melanoma [7].

Who is at Risk for Developing Melanoma?
There are certain risk factors that can increase a person’s chance of developing
melanoma. People that have been exposed to more risk factors are at a higher risk for
developing melanoma than others. A risk factor is anything that raises a person’s chance
of developing a disease, such as cancer. Some risk factors are characteristics that can be
inherited; others are due to the environment the person has been exposed to during his or
her lifetime. Examples of risk factors include: exposure to ultraviolet light, a large
number of moles on the skin, fair skin, and a family history of melanoma.
High exposure to ultraviolet light is the most significant risk factor for the
development of melanoma. Exposure to ultraviolet light can damage the DNA in
melanocytes, which can cause mutations that lead to cancer [7]. High ultraviolet
exposure also increases the production of melanin by the melanocytes. If the
melanocytes become fatigued, it is possible that they will be more likely to develop into
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melanoma [7]. Areas of previous severe sunburns are also more likely to develop
melanoma due to ultraviolet damage.
Another risk factor in the development of melanoma is a large number of nevisent
on the body. Most people have nevi, and usually these nevi will not become cancerous.
But anyone with over 50 nevi on their body is at a higher risk of at least one nevus
becoming cancerous [12]. Another risk factor associated with nevi is the presence of
dysplastic nevi, which are abnormal nevi. It has been shown that nevi that are abnormal
in size and shape, or have the appearance of melanoma, are more likely to develop into
melanoma. A dysplastic nevus has a 6% to 10% chance of becoming cancerous during
the lifetime of the person. The development of dysplastic nevi and their correlation with
melanoma is hereditary. A person with a family history of melanoma is 50% more likely
to develop melanoma themselves [7].
A family history of melanoma is a risk factor for the development of the disease.
Ten percent of people who have been diagnosed with melanoma already have had a close
family member (parent, sibling, or child) diagnosed with the disease. The increased risk
for people with family members already diagnosed with melanoma may be due to
inherited traits or similar lifestyles [12].
Fair skin, light eyes, and light colored hair are other risk factors in the
development of melanoma [9]. People with light skin have less melanin in their skin to
protect the DNA in their skin from ultraviolet light. The protective effects of high
amounts of melanin can be best seen when comparing the diagnosis rates of melanoma
between Caucasians, who have low amount of melanin, with African Americans, who
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have comparatively high amounts of melanin. Caucasians are more than 10 times more
likely to develop melanoma than African Americans [7].

Diagnosing Melanoma
For all cancers, the early diagnosis of the disease can greatly improve the
prognosis. It is important to correctly diagnose cancer early in order to start treatment
and stop the disease from spreading to other tissues. If the cancer is allowed to spread to
other areas of the body, it becomes harder to treat and the chance of death increases. The
initial diagnosis of melanoma is done visually, and then confirmed pathologically. A
diagnosis is made by a doctor. If a doctor suspects melanoma after a visual inspection,
they can perform an excisional or incisional biopsy to confirm the diagnosis.
The first sign of melanoma is the change in appearance of an existing nevus or the
appearance of a new nevus. Doctors use the ABCD method as a rule for visually
diagnosing melanoma. Each letter stands for a warning sign of melanoma (see Figure 5
[4]). They are as follows [12]:


A-asymmetry. The shape of one half of the mole does not match the other.



B-border. The edges of the mole are ragged, blurred, or irregular.



C-color. The color of the mole is uneven, or contains multiple colors.



D-diameter. The mole increases in diameter.
If after using this method the doctor suspect’s melanoma, they will make a biopsy

to send to a pathologist, who will then make a more definitive diagnosis. The pathologist
will look at the tissue sample under a microscope to determine if it contains cancerous
cells.
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Figure 5 – Melanoma ABCDs
The 4 signs of melanoma used to make a visual diagnosis
There are two types of biopsies used to diagnose melanoma: excisional and
incisional biopsies. In an excisional biopsy, the doctor will remove the entire suspected
tumor. A downside to an excisional biopsy is that since a large amount of tissue is
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removed, healing times can be long and a scar where the tissue was removed may result
[7]. In an incisional biopsy, the doctor only removes a portion of the tumor. There are
two types of incisional biopsies: a shave biopsy and punch biopsy. In a shave biopsy, the
doctor shaves off the top layer of skin with a scalpel. Shave biopsies are not often used
when melanoma is suspected because the tissue sample may not be thick enough to
determine how deep the melanoma has progressed through the skin [7]. In a punch
biopsy, the doctor uses a tool that resembles a small cookie cutter to remove a core
sample of the tumor. This sample includes deeper tissue such as the dermis and upper
subcutis.
All melanoma diagnosis techniques currently used are invasive to the patient and
can lead to scarring of the skin. A diagnosis method that does not cause damage to the
skin is desired by patients and physicians. The purpose of the experiments performed
later in this thesis is to develop a non-invasive diagnosis method for melanoma.

Staging Melanoma
Once a positive diagnosis of melanoma has been made, the extent to which the
disease has grown and spread through the body must be determined. Cancer can spread
through the body in three ways. The first is by growing and invading the surrounding
tissue. Another way cancer can spread is through the lymph vessels and nodes. In this
method, cancer cells break off from the original tumor and enter the lymph system and
travel to other parts of the body where they can then become established in other tissues.
This form of spreading through the body is called metastasis (see Figure 6 [6]). The final
way cancer can spread through the body is entering the bloodstream and traveling to
other areas of the body via the blood vessels, which is another form of metastasis [1].
14

Figure 6 – Melanoma Metastasis
The invasion and metastasis of melanoma
The process of determining how large the tumor has grown and how far the cancer
has spread is called staging. To stage cancer, more tests must be performed. The stage of
the cancer greatly effects the treatment and prognosis, as cancers that have progressed
further will be harder to treat.
To stage melanoma, additional tests are performed by a doctor. After the initial
biopsy to diagnose the cancer, a sentinel lymph node biopsy may be performed. In this
procedure, radioactive dye is injected into the skin near the site of the tumor. The doctor
watches the flow of the dye through a fluoroscope as it travels through the lymph system
to the nearest lymph node (the sentinel lymph node). The doctor will then remove this
lymph node and send it to a pathologist to determine if cancer cells have traveled to it [1].
Other tests include a chest x-ray, CT scan, MRI, and blood tests. All these tests are used
to determine if the cancer has spread from the original site to other tissues in the body.
Once the doctor knows how far the cancer has spread, if at all, a stage can be assigned to
the cancer.
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The purpose of staging cancer is to give the doctor an easy and fast way of
communicating information to other doctors about how far a case of cancer has
progressed in a patient. By having standard criteria for describing the state of cancer in
different patients, treatment options can also be standardized.
Staging of cancer includes three different categories: T, N, and M. Each letter
stands for a certain characteristic of the cancer and contains important information about
the stage of the cancer. The following descriptions of the T, N, and M categories are
taken from American Cancer Society's Guide to Understanding Melanoma [7].



The T category stands for tumor. The T category is assigned a number (from 0 to
4) based on the tumor's thickness (how far into the skin it has grown). It is also
assigned the letter "a" if it is not ulcerated or a "b" if it is ulcerated. Ulceration
means a layer of skin covering the melanoma is absent. Ulceration is determined
under a microscope after a biopsy.


To assign a T value to a case of melanoma, a physician uses a micrometer to
measure how deep the cancer has spread on a tissue sample from a biopsy.
The possible values of T are as follows:
■













TX: Primary tumor cannot be assessed.
T0: No evidence of primary tumor.
Tis: Melanoma in situ (the cancer has not moved from the original site).
T1a: The melanoma is less than or equal to 1.0 mm thick, without
ulceration.
T1b: The melanoma is less than or equal to 1.0 mm thick, with ulceration.
T2a: The melanoma is between 1.01 and 2.0 mm thick without ulceration.
T2b: The melanoma is between 1.01 and 2.0 mm thick with ulceration.
T3a: The melanoma is between 2.01 and 4.0 mm thick without ulceration.
T3b: The melanoma is between 2.01 and 4.0 mm thick with ulceration.
T4a: The melanoma is thicker than 4.0 mm without ulceration.
T4b: The melanoma is thicker than 4.0 mm with ulceration.

The N category stands for spread to nearby lymph nodes (see Figure 7 [11] on
how a sentinel lymph node biopsy is preformed). The N category is assigned a
number (from 0 to 3) based on whether the melanoma cells have spread to lymph
nodes or are found in the lymphatic channels connecting the lymph nodes. The N
category is also assigned the letter "a" if melanoma cells can only be seen under a
microscope or the letter "b" if they can be seen with the naked eye. The letter "c"
16

is assigned if there are very small amounts of melanoma in the nearby skin or if
the melanoma is in skin lymphatic channels around the tumor.

Figure 7 – Sentinel Node Biopsy
How a sentinel lymph node biopsy is performed


To assign an N value to a case of melanoma, the results of a sentinel lymph
node biopsy are used. The possible values of N are as follows:
■











NX: Nearby lymph nodes cannot be assessed.
N0: No spread to nearby lymph nodes.
N1a: The melanoma has spread to 1 nearby lymph node and the
melanoma in the lymph node is only seen under the microscope.
N1b: The melanoma has spread to 1 nearby lymph node and the
melanoma in the lymph node is visible to the naked eye.
N2a: The melanoma has spread to 2 or 3 nearby lymph nodes and the
melanoma in the lymph node is only seen under the microscope.
N2b: The melanoma has spread to 2 or 3 nearby lymph nodes and the
melanoma in the lymph node is visible to the naked eye.
N2c: The melanoma has spread to 2 or 3 nearby lymph nodes, or the
melanoma has spread to very small areas of nearby skin, or has spread to
skin lymphatic channels around the tumor.
N3: The melanoma has spread to 4 or more lymph nodes, or spread to
lymph nodes that are clumped together, or spread to nearby.

The M category is based on whether the melanoma has metastasized to distant
organs.


To assign an M value to a case of melanoma, the results of the chest x-ray,
MRI, CT scan, and/or blood tests are assessed by a doctor. The possible M
values are as follows:
■


MX: Presence of distant metastasis cannot be assessed.
M0: No distant metastasis.
17





M1a: Distant metastases to skin or subcutaneous (below the skin) tissue or
distant lymph nodes.
M1b: Cancer cells have metastasized to the lung.
M1c: Cancer cells have metastasized to other organs

To make staging information even more accessible, a technique called stage
grouping is also used. Stage grouping is a process where common combinations of the T,
N, and M stages are combined into even simpler groups, and are labeled: I, II, III, or IV.
In general, patients with a lower stage grouping will have a better chance of surviving
their cancer. The following are the stage groupings for melanoma as stated by the
American Cancer Society's Guide to Understanding Melanoma [7]:


Stage 0
Tis, N0, M0: The melanoma is in situ, meaning that it involves the epidermis but
has not spread to the dermis (see Figure 8 [1]).

Figure 8 – Stage 0 Melanoma
The appearance of stage 0 melanoma


Stage IA
T1a, N0, M0: The melanoma is less than 1.0 mm in thickness. It is not ulcerated,
appears to be localized in the skin, and has not been found in lymph nodes or
distant organs (see Figure 9 [1]).



Stage IB
T1b or T2a, N0, M0: The melanoma is less than 1.0 mm in thickness and is
ulcerated or, or it is between 1.01 and 2.0 mm and is not ulcerated. It appears to
be localized in the skin and has not been found in lymph nodes or distant organs
(see Figure 9 [1]).
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Figure 9 – Stage I Melanoma
The appearance of stage I melanoma


Stage IIA
T2b or T3a, N0, M0: The melanoma is between 1.01 mm and 2.0 mm in
thickness and is ulcerated, or it is between 2.01 and 4.0 mm and is not ulcerated.
It appears to be localized in the skin and has not been found in lymph nodes or
distant organs (see Figure 10 [1]).

Figure 10 – Stage II Melanoma
The appearance of stage II melanoma


Stage IIB
T3b or T4a, N0, M0: The melanoma is between 2.01 mm and 4.0 mm in
thickness and is ulcerated, or it is thicker than 4.0 mm and is not ulcerated. It
appears to be localized in the skin and has not been found in lymph nodes or
distant organs (see Figure 10).
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Stage IIC
T4b, N0, M0: The melanoma is thicker than 4.0 mm and is ulcerated. It appears
to be localized in the skin and has not been found in lymph nodes or distant
organs (see Figure 10).



Stage IIIA
T1a-4a, N1a or N2a, M0: The melanoma is not ulcerated. It has spread to 1-3
lymph nodes near the affected skin area, but the nodes are not enlarged and the
melanoma is found only when they are viewed under the microscope. There is no
distant metastasis. The thickness of the melanoma is not a factor (see Figure 11
[1]).

Figure 11 – Stage III Melanoma
The appearance of stage III melanoma


Stage IIIB
T1b-4b, N1a or N2a, M0: The melanoma is ulcerated. It has spread to 1-3 lymph
nodes near the affected skin area, but the nodes are not enlarged and the
melanoma is found only when they are viewed under the microscope. There is no
distant metastasis.
T1a-4a, N1b or N2b, M0: The melanoma is not ulcerated. It has spread to 1-3
lymph nodes near the affected skin area. The nodes are enlarged because of the
melanoma. There is no distant metastasis.
T1a/b-4a/b, N2c, M0: The melanoma can be ulcerated or not. It has spread to
small areas of nearby skin or lymphatic channels around the original tumor, but
the nodes do not contain melanoma. There is no distant metastasis.
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Stage IIIC
T1b-4b, N1b or N2b, M0: The melanoma is ulcerated. It has spread to 1 to 3
lymph nodes near the affected skin area. The nodes are enlarged because of the
melanoma. There is no distant spread.
Any T, N3, M0: The melanoma can be ulcerated or not ulcerated. It has spread to
4 or more nearby lymph nodes, or to nearby lymph nodes that are clumped
together, or it has spread to nearby skin or lymphatic channels around the original
tumor and to nearby lymph nodes. The nodes are enlarged because of the
melanoma. There is no distant metastasis.



Stage IV
Any T, Any N, M1: The melanoma has spread beyond the original area of skin
and nearby lymph nodes to other organs such as the lung, liver, or brain, or to
distant areas of the skin or lymph nodes. Neither the lymph node status nor
thickness is considered, but typically the melanoma is thick and has also spread to
lymph nodes (see Figure 12 [11]).

Figure 12 – Stage IV Melanoma
The appearance of stage IV melanoma
Other factors that affect the prognosis and treatment decisions for melanoma are
the location of the tumor on the body, the mitotic index of the cancer cells, the presence
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of tumor infiltrating lymphocytes, and the number of regional lymph nodes involved [11].
After all these factors have been considered, a course of treatment can be chosen.

Current Treatment Options for Melanoma
The current treatment methods for melanoma will now be discussed. Knowledge
of these methods will become important when discussing the possibility of using
radiofrequecy tissue ablation to treat melanoma in the “Next Steps: Diagnose and Treat
Melanoma” section.
The cure rate for melanoma is directly related to the stage of the cancer and the
treatment used [13]. Once melanoma has been properly diagnosed and staged by a
physician, a course of treatment can be chosen. The type of treatment that is used to treat
the cancer depends on the stage of the melanoma. The most common method of
treatment for melanoma is surgery to physically remove the cancer cell, chemotherapy,
immunotherapy, or radiation therapy. A combination of multiple methods may also be
used.
Surgery to remove the tumor is the most common method of treatment for
melanoma [12]. Surgery is also the popular method of treatment when the melanoma is
still in the early stages of growth. A surgeon may use a variety of techniques to
physically remove the tumor from the body or to kill the cancer cells to stop them from
spreading. These techniques include: simple excision, electrodesiccation and curettage,
Mohs surgery, and cryosurgery.
Simple excision is similar to a biopsy. A doctor cuts out the tumor using a scalpel,
along with some surrounding healthy skin tissue [5]. Healthy tissue is also removed as a
way to help assure that all the cancerous cells are removed. If all the cancerous cells are
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not removed, the melanoma may reappear. The margin of how much healthy tissue is
removed depends on how large the melanoma tumor is. Table 1 shows the margin of
healthy tissue removed in relation to how thick the original tumor is [7]:
Table 1 – Tumor Excision Margins
Tumor Thickness Margin of Healthy Skin Removed
In situ

.5 cm

<1 mm

1 cm

1 to 2 mm

1 to 2 cm

2 to 4 mm

2 cm

>4 mm

At least 2 cm

After the doctor removes the tumor, the skin is stitched back together at the
surgery site. A scar will often form in the place of the incision. If a large amount of skin
had to be removed, sometimes the doctor will perform a skin graft to cover the wound
[7].
Another type of surgery to remove melanoma is called electrodesiccation and
curettage. With this technique, the doctor first cuts out the melanoma tumor using a tool
called a curette; a small, sharp, spoon shaped tool. The doctor then treats the area with
electricity from a monopolar electrode to stop any bleeding and to kill any remaining
cancer cells (see the “Monopolar versus Bipolar Electrodes” section for a discussion on
how a monopolar tissue ablation system functions). This process may then be repeated as
necessary. Like simple excision, electrodesiccation and curettage may leave a scar.
Mohs surgery is another type of surgery to remove melanoma. It is a technique
that can only be performed by specially trained physicians. For this treatment method,
the doctor first removes the visible tumor, while also only removing a very small margin
of healthy skin (typically only 1 mm). The removed skin is then sectioned, stained, and
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examined under a microscope. If cancer cells are detected in the sample, the doctor
removes another thin slice of tissue in the area of where the cancer cells were seen. The
process is repeated until no cancer cells can be identified under the microscope. This
technique is useful in that very little healthy tissue is removed, which leads to smaller
scars (see Figure 13 for an example of a scar caused by Mohs surgery [photo courtesy of
Marlene Stante]). However, not all doctors can perform Mohs surgery [5].

Figure 13 – Mohs Surgery Scar
The scar left on a patient as a result of Mohs surgery
Another technique used to treat skin cancer surgically is cryosurgery.
Cryosurgery uses liquid nitrogen applied to the tumor to freeze the cancer cells (see
Figure 14 [1]). When the cells freeze, the water in the cytoplasm of the cells expands
until the cell burst, killing the cell. After the treated tissue thaws, blisters may form on
the area of treatment. Healing may take 1 to 2 months and a scar will likely form. The
treated area will also have less pigmentation once the skin heals [5].
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Figure 14 – Cryosurgery
An example of using cryosurgery to treat
skin cancer
Chemotherapy is a type of treatment used to treat melanoma that has progressed
further than the early stages and to other areas of the body. Chemotherapy uses anticancer drugs to kill the cancer cells. There are three ways that the anti-cancer drugs can
be administered to the patient: orally, intravenously, or through a technique called
isolated limb perfusion. In isolated limb perfusion, blood flow to the arm or leg that has
the melanoma is stopped using a tourniquet. The cancer drug is then injected into the
limb. This technique allows the drug to be given in higher doses, reach the tumor site
more directly, and to stay in the area for a longer period of time. No matter what delivery
method is used, the anti-cancer drug travels through the blood stream and reaches all
parts of the body. This means that chemotherapy can affect the entire body, not just the
tumor site. The most common anti-cancer drugs used in chemotherapy are Dacarbazine,
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Cisplatin, Vinblastine, DTIC, Temozolomide, and Paclitaxel [12]. These drugs may be
administered by themselves or in combination with the other drugs. The drugs function
by attacking cells that divide quickly, such as cancer cells. The drugs interfere with the
cancer cells' abilities to replicate, thus stopping growth and killing the tumor.
Chemotherapy drugs cause side effects, such as: loss of appetite, nausea and vomiting,
lowered resistance to infection (due to low white blood cell counts), easy bruising or
bleeding (due to low blood platelets counts), fatigue (due to low red blood cells counts).
Since the drugs effect cells in the body that divide quickly, hair loss can also occur
because hair follicles contain cells that divide quickly [7].
Immunotherapy is a type of cancer treatment that is often used alongside
chemotherapy. Like chemotherapy, immunotherapy is used for cases of melanoma that
have progressed beyond the early stages. Immunotherapy works to fight cancer by
increasing the body's own immune response to kill cancer cells. Two immunotherapy
drugs that are used to treat melanoma are interferon-alpha and interleukin-2. Both of
these are a classification of drugs called cytokines, which are manmade versions of
substances naturally found in the body. The drugs function by activating the body's
natural immune response to fight off a pathogen. Because the drugs are released into the
blood stream, they can be used to fight cancer cells throughout the body that may have
spread from the original tumor. Some side effects of immunotherapy drugs include:
fever, chills, aches, severe tiredness, drowsiness, and low blood cell counts [7].
Radiation therapy is the final method of treatment for melanoma. Radiation
therapy is usually reserved for cases of melanoma that have progressed to later stages and
have metastasized to other tissues in the body. Radiation might also be used alongside
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surgery at the treatment site, in order to destroy any remaining cancer cells. Radiation
therapy uses high levels of ionizing radiation to kill cancer cells [7]. The side effects of
radiation therapy to treat melanoma includes: red or dry skin and fatigue [12].
These treatment options can often be effective in treating skin cancer, as long as
the treatment starts at an early stage. However, many of the treatment methods have
undesirable side effects including: scarring of the skin, fatigue, loss of appetite, nausea
and vomiting, lowered resistance to infection, easy bruising or bleeding, fever, chills,
aches, severe tiredness, drowsiness, and low blood cell counts. A new method of cancer
treatment that can effectively treat skin cancer yet not cause these harmful side effects is
desired by doctors and patients. It may be possible that radiofrequency tissue ablation
could be this treatment method. For a further discussion about the future possibility of
radiofrequency tissue ablation to treat skin cancer, please see the “Radiofrequency Tissue
Ablation” section.

Melanoma Statistics
This section will provide statistical data about the incidence, morbidity, and
mortality of melanoma. This section will also present incidence and mortality statistics
for all types of cancer, in order to make a qualitative comparison with melanoma.
Cancer is the second leading cause of death in the United States (heart disease is
the leading cause of death). Cancer is the cause of 1 in every 4 deaths in the United
States [9]. It is estimated that 565,650 people died from cancer in the United States in
2008, which is approximately 1500 deaths from cancer per day [14]. Cancer was the
cause of death for 7.6 million people throughout the world in 2007 [7]. The incident rate,
which is the number of new diagnoses during a specific time frame, for all types of
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cancer in 2008 was 745,180 for men and 692,000 for women [14]. The age adjusted
incident rate, which is a method of standardizing the age of a population so populations
of different average ages can be compared (since the patient’s age greatly effects the
chance of diagnosis, populations with different average ages will have different incident
rates), for all types of cancer based on data from 2001 to 2005 was 467.4 per 100,000
men and women per year. The median age at diagnosis is 67, while the median age at
death from cancer is 73 [14]. Based on data from 2003 to 2005, 40.35% of men and
women born today will be diagnosed with cancer during their lifetime. The lifetime risk
of an individual in the United States for developing and dying from cancer is
approximately 50% for men and approximately 33% for women [9].
Cancer of the skin is the most common type of cancer. Skin cancer (including
basal and squamous cell cancer) accounts for approximately half of all cancers [5].
Melanoma, as has been previously stated, is the most deadly type of skin cancer. 34,950
men and 27,530 women were diagnosed with melanoma in the United States in 2008
[14]. The percentage of people that develop melanoma has doubled in the last 30 years
[12]. Melanoma is the 6th most common type of cancer for men, with melanoma
accounting for 5% of all new cancer cases. Melanoma is the 7th most common type of
cancer for women, with melanoma accounting for 4% of all new cancer cases [9]. The
age adjusted incident rate for melanoma based on data from 2001 to 2005 was 19.4 per
100,000 men and women. White males are the most likely group to be diagnosed with
melanoma, with an incident rate of 28.5 per 100,000. 1.81% of people born today will be
diagnosed with melanoma sometime during their lifetime [14]. Males have a 2.42%
chance of developing melanoma during their lifetime, while females have a 1.63%
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chance of developing melanoma during their lifetime. In the United States, California
has the greatest number of new cases. It is estimated that in California there were 7,620
new diagnoses of melanoma in 2008 [9]. The median age at diagnosis for melanoma is
59. The prevalence of melanoma, which is the number of people who are alive today and
have a history of the disease, is 723,416 [14].
Once melanoma has been diagnosed, the most important factor that affects the
patient's chance of survival is the thickness of the tumor. Melanoma tumors that are less
than 1mm in thickness have a 10 year survival rate of 95%, which is the patient’s chance
of surviving 10 years after diagnosis. If the melanoma is diagnosed later, the tumor will
have had time to grow and spread, and the 10 year survival rate decreases. A tumor that
is 1 mm to 2 mm thick has a 10 year survival rate of 80%. Tumors with a thickness of 2
mm to 4 mm have a 10 year survival rate of 55%. If that tumor is larger than 4 mm, the
10 year survival rate drops to 30% [15]. Similar to tumor thickness, melanoma survival
rates are also affected by what stage the cancer is in when it is diagnosed. Table 2 shows
the survival rates for melanoma by stage [7]:
Table 2 – Melanoma Survival Rates by Stage
5 year (%)

10 year (%)

IA

99

97

IB

92

86

IIA

78

66

IIB

68

59

IIC

56

48

IIIA

Not Available

Not Available

IIIB

50-68

44-60

IIIC

27-52

22-37

IV

18

14
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As the table shows, as melanoma spreads and progresses, it becomes more
difficult to treat, and the chance of survival is reduced. Eighty percent of melanoma is
diagnosed in the localized stage, which helps to keep deaths from melanoma low
compared to the number of diagnoses and to other cancers [9]. The mortality of
melanoma, which is the number of deaths during a specific time frame, in 2008 was
8,420 men and women. Melanoma accounts for less than half of all new skin cancer
cases but causes the majority of deaths [7].
Melanoma not only takes lives, but also puts a very large burden on the economy.
It is estimated that the cost of cancer was $219.2 billion in 2007 [9]. This includes direct
medical costs toward fighting cancer, lost productivity costs due to illness from cancer,
and lost productivity costs due to premature death from cancer. Eighty-nine billion
dollars was spent in 2007 toward diagnosing and treating cancer. It is very important to
diagnose melanoma early since the stage of the cancer at the time of diagnosis greatly
affects the patient’s chance of survival. Since all of the current melanoma diagnosis
techniques involve invasive procedures, doctors may be unwilling to perform biopsies on
nevi that only have a slight chance of being cancerous. This may allow for some
melanoma to “slip through the cracks” and progress to later stages when they could have
been diagnosed earlier. A non-invasive diagnosis technique is needed. Diagnosing
melanoma by comparing the electrical properties of the suspected tumor to known values
of healthy and cancerous skin may be able to fill this need, and is the main objective of
this thesis.

30

Electrical Properties of Skin
Introduction to Electrical Properties
This section will give an overview of the electrical properties of skin tissue. Since
the new technology for the diagnosis of skin cancer investigated in this thesis and the
future research into radiofrequency tissue ablation will use electricity, it will be important
to understand how the skin conducts electricity. It will also be important to have an
understanding of the electrical properties of cancer. Using information on the differences
between the electrical properties of healthy skin tissue and cancer will allow a device to
detect skin cancer and also assist in treating the cancer with radiofrequency tissue
ablation.
It will be helpful to have an understanding on the electrical properties terms that
are discussed in this thesis. Resistance is a measure of the amount of resistance to current
flow through a material when a given voltage gradient is applied. Resistance of a
material is determined by the number of free electrons and ions available to flow through
the material and act as charge carriers. Capacitance is the ability of a material to hold a
charge when a voltage gradient is applied. When the voltage source is removed, the
voltage difference between the two areas remains and begins to decay at a rate
determined by the material properties and structure. Impedance is a measure of a
material’s resistance to an applied alternating current. It is a combination of resistance
and reactance (which is a method of measuring capacitance at certain frequencies, see
Equation 3).
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Physical Makeup and Electrical Properties
The electrical properties of biological tissues result from the interaction of the
applied electromagnetic radiation and the constituents of the tissue at the cellular and
molecular level [16]. The relative amounts and positions of the tissues on the micro scale
and their specific resistances to high frequency current control the current distribution of
the tissue on the macro scale [17]. Three other factors that greatly affect the electrical
properties of tissue include: the polarization of water molecules, the polarization of cell
membranes which act as barriers to the flow of ions in and out of the cell, and ionic
diffusion through the cellular membrane [16].

Electrical Properties of Skin
Human skin tends to have high electrical impedance compared to other biologic
tissues due to the properties of the stratum corneum [18]. It has been shown that skin has
a statistically higher impedance than the other tissues of the body [19]. These higher
impedances are caused by lower water content and the physical structure of the stratum
corneum compared to other tissues.
The stratum corneum is believed to have high impedance because of the low
water content of the tissue compared to other tissues in the body. Tissues with a similar
amount of water content have been shown to have similar resistivities [19]. Water and
the ions that are suspended in it, act as a medium that allows for current to flow. When
water content goes down in a tissue, the ability for that tissue to transport an electrical
current diminishes. As a result, the resistance of that tissue increases.
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In addition to effecting the resistive properties of skin, water also affects the
capacitive properties. Capacitance of skin also increases with increasing water content
[20]. Previous research has shown that the capacitor properties of the stratum corneum
are completely dependent on the amount of contained water. When the stacked structure
of skin cells becomes hydrated, the tissue acts like a capacitor because of the presence of
layers of phospholipid membranes.
Research has also found that the impedance of skin decreases as deeper layers of
the stratum corneum are exposed. This is because the water content of the skin increases
with an increasing depth from the surface. However, even at the same depth, not all skin
has uniform impedance properties. Skin lesions, along with the limbs of the body, have
lower water content, and thus higher impedances [18]. The water content of skin can
vary with the seasons, time of day, and temperature [21].
Along with the amount of water in the tissue, the physical structure of the tissue
can have an impact on the ability of current to flow, and thus influence the electrical
properties of the tissue. An example of the physical structure of a tissue affecting the
electrical properties of that tissue is muscle fibers. Muscle cells have an elongated shape,
filled with cytoplasm. They are bundled into larger structures called fibers. The
cytoplasm acts as an electrolyte and makes the fibers analogous to bundles of conducting
wire. Because of this structure, muscle fibers have a much lower resistance in the
direction of the fibers relative to the resistance across the fiber [22]. This suggests that
biologic tissues can have different electrical properties depending on the direction of the
measurement relative to physical structures. The physical structure of tissues also
account for the high impedances observed. Each cell in a biologic tissue has a radius of
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approximately 10 nanometers, and each has its own intrinsic resistance and capacitive
properties. When a measurement of a 1 centimeter long sample is taken, approximately
1,000 cells are connected in series. The resistance of the entire sample increases by a
factor of 1,000 while the capacitance is reduced by a factor of 1,000 (since capacitor
elements add up inversely), compared to the original cell [10].
The electrical properties of skin can be modeled as an equivalent circuit of a
parallel resistor and capacitor. Although, since the skin is non-uniform, when a voltage is
applied the current flow is also non-uniform. The resistor of the equivalent circuit can be
seen as an ionic conductor with a resistance that falls as the number of charge carriers
increase [23].

Electrical Properties of Cancer
Along with an understanding of the electrical properties of normal, healthy skin, it
is also important to have an understanding of the electrical properties of cancerous
tumors. Knowing how the electrical properties of cancer differ, if at all, from healthy
tissue, will allow one to be more confident in the data and conclusions that are presented
later in this thesis.
The average cell radius of a cancerous tumor is lower than that of a healthy cell.
This means that the cellular volume fraction of a tumor is higher than normal tissue.
Tumors also have an increased amount of epithelial cells. The increase of cellular
density and epithelial cells means that the amount of cytoplasm in a given amount of
cancerous tissue increases. Since cytoplasm is a good conductor because it allows the
free flow of ions, the resistance of tumors decreases compared to normal tissue. Tumors
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also have an increased amount of extracellular fluid, which functions in a similar way to
lower the resistance of the tumor [10].

Practical Observations
From previous research into the electrical properties of biologic tissues, there are
some interesting attributes of tissues that are good to keep in mind when taking
measurements of the electrical properties of skin tissue. The first is that the resistance of
biological tissue is dependent on the frequency of which the measurement is taken at.
Biologic tissue resistance has an inverse relationship with frequency [24]. As the
frequency of the measurement signal increases, the resistance of the tissue decreases.
This is due to the fact that at low frequencies, the ion densities around the area of the
measurement probe increases, impeding the travel of current through the tissue. The
amount of the effect the frequency has on resistance has been quantified in previous
research. Resistivity decreases by 10-20% in an increase from 1 kHz to 10 kHz and 50%
from 1 kHz to 100 kHz measurement frequency. Conversely, resistivity rises 5% in a
decrease in frequency from 1 kHz to 100 Hz and 20% in a change from 1 kHz to 10Hz
[25].
Another interesting attribute of the electrical properties of biologic tissue is that
the resistance of biologic tissue increases with tissue necrosis. This is caused by the fact
that when a cell dies, the cell membrane loses its’ ability to maintain its’ insulating
properties and ionic gradients [22]. Other research has confirmed this observation, noting
that tissue undergoes large changes upon death of the cell, especially in low frequency
ranges. This is important to note because an electrical current will follow a path that
offers the least resistance. This holds true for when the current is passing through
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biologic tissues, as a current that transverses a tissue sample will follow the path of least
electrical resistance and will avoid tissues of higher resistance [17]. The fact that tissue
impedance increases as cell necrosis progresses will be important to keep in mind in the
“Radiofrequency Tissue Ablation,” as many radiofrequency ablation generators use this
phenomenon to monitor the progress of treatment.

Previously Recorded Values
When reporting values for the resistance of biologic tissues, researchers convert
resistance values into units of resistivity, or specific resistance. This converts the values
from units of Ohms to units of Ohms*cm. To make this conversion, Equation 1 is used
[17]:
Equation 1-Specific Resistance:
RS = RM * SA / DE
Where:
RS = Specific resistance
RM = Measured resistance
SA = Electrode surface area
DE = Distance between electrodes

The purpose of making this conversion is to control for different-sized electrodes
and electrode spacing that are used by different groups of researchers. By reporting
specific resistance instead of measured resistance, researchers are able to compare values,
even though those values were recorded using different experimental setups. There are
two electrode setups that are used most commonly to determine the impedance of
biologic tissues. One system uses two electrodes, known as a Schwan electrode to drive
a current through tissue and obtains measurements using the same two electrodes (see
figure 15 [25]).
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Figure 15 - Schwan Electrode
An example of a Schwan electrode
The other system uses four electrodes. In the four electrode setup, the two outer
electrodes drive a current through the tissue, while the two inner electrodes are the
measurement electrodes (see Figure 16, where electrodes S1 and S2 drive the electrical
current and electrodes m1 and m2 measure the electrical properties [25]). Some believe
that the 4 electrode system prevents polarization (or the buildup of ions) at the
measurement electrodes which can lead to artificially higher values for the resistance.
Other research has suggested that there is no significant difference between the two
setups [24]. Other research has also found that the four electrode system does not
eliminate polarization [25]. The electrode setup that was used by the author of this thesis
most closely resembles the Schwan electrode.
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Figure 16 – 4 Electrode Tissue Probe
A schematic of a 4 electrode 3 tissue probe
Below are the summarized tissue resistance values found in the literature. The
values for muscle and fat are also included because they may be important to quantifying
the electrical properties of a tumor that have advanced into deeper tissue. The purpose
of listing these previous measurements of the electrical properties of biologic tissues is to
show that since there is little agreement among experts on the methods used and results
obtained, it does not make sense to compare these measurements with data found during
experiments performed for this thesis. It is important to note that no previous research
into the area of measuring the electrical properties of melanoma or comparing the
electrical properties of normal and cancerous tissue was found in the literature.
Hemingway and McClendon found skin to have a specific resistance of
289 Ohms*cm, fat to have a specific resistance of 2,180 Ohms*cm, and Muscle
tissue to have a specific resistance of 110 Ohms using the 2 electrode setup and a
frequency of 1MHz [17].
Geddes and Baker found that human muscle has a specific resistance of
110 Ohms*cm at 1MHz (2-pp284). They measured dog fat as having a specific
resistance of 1500-3000 Ohms*cm at 10-100 kHz. They also used a 2 electrode
setup [22].
Burger and VanDonger found that the specific resistance of muscle fibers
varies by 3% between the longitudinal and transverse directions. They found that
on average, muscle fibers have a specific resistance of 675 Ohms*cm [24].
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Gabriel and Corthout found that when measured at 10,000 Hz, human skin
has a permittivity of 1E5 to 1E3 Farads/meter and a conductivity of 0.5E-1 to 1E4 Siemens/meter [16].
Faes and Meij found skin to have a specific resistance of 329 Ohms*cm
[20].
One can see that there seems to be little agreement about the specific resistances
of skin and other tissues. This can be attributed to variations in the measurement
apparati, measurement frequencies, and experimental procedures used by each researcher.
Other factors such as in vivo versus in vitro, temperature, and time after excision could
have caused the differences in results. In addition, these measurements of tissue
resistance were taken in order to learn about different characteristics of the tissue, such as
hydration. For some, the measurements were taken with the purpose of being compared
to other tissues, instead of just investigating the properties of the tissue themselves.
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Experimental Methods
Introduction to Experimental Methods
The following sections will outline the thought process and the steps that were
taken in measuring the electrical properties of human skin analogues. The purpose for
measuring the electrical properties of human skin analogues is to illustrate the concept
that a bipolar measuring system can reliably distinguish between normal and cancerous
skin tissue.

Purpose of Measuring Electrical Properties of Skin Analogues
The purpose of measuring the resistance and reactance (which will also
sometimes be referred to as, “electrical properties”) of skin analogues for this thesis is to
attempt to conclude if skin with melanoma cells has a measurable difference of electrical
properties compared to healthy, non cancerous skin. If a difference can be reliably
detected between the two tissue types, a device can be made that diagnoses cancer by
measuring the electrical properties of the tissue. Measurable different electrical
properties could also let a device map out the border of the lesion against healthy tissue.
Being able to map out the border of where healthy and cancerous tissue meet would
allow the device to apply treatment only to the cancerous tissue and avoid an invasive
procedure for both diagnosis and treatment.
A melanoma diagnosis system that functions by measuring the electrical
properties of the suspected tumor is desirable because, as was shown earlier, all current
diagnosis methods are invasive to the patient. Surgery and scarring of the skin are a
result of the melanoma diagnosis techniques. A technique that compares the measured
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electrical properties of the suspected tumor to known values of melanoma and healthy
skin to make a diagnosis would be less invasive to the patient and cause no lasting
effects.

Experimental Measurement Materials
The following sections detail the experimental setups that were used for each
experiment that was performed to gather data for this thesis.

Electrode Fixture
Since the measured resistance and capacitance of a tissue sample is a function of
the amount of tissue being measured (as evident by Equation 1), the distance between the
electrodes must be the same for each trial. In order to provide a consistent electrode
setup for measuring the electrical properties of skin tissue analogues between samples
and trials, an electrode fixture had to be designed and manufactured. The fixture allowed
the electrodes to be held at a consistent distance away from each other.
Several design considerations went into the design of the electrode fixture in order
to ensure that the fixture functioned as needed. These considerations included: ease of
manufacture, material, suitable dimensions, ability of replace electrodes as needed, and
usability.
In order to ensure that the electrode fixture could be easily and quickly
manufactured, a cylindrical design was chosen, allowing the fixture to be made on a
lathe. The main body of the fixture consists of a solid cylinder with a post protruding
from one face (see part labeled 1 on Figure 17). Through the body of the cylinder are two
through holes that allow the wires of the electrodes to pass though. A cylindrical tube
goes over the post (see part labeled 2 on Figure 17). This tube has two grooves on the
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inner diameter where the electrodes are held. Screws on the tube allow the tube to be
tightened onto the post; securing the electrodes in place and also allowing the tube to be
removed to access the electrodes (see Figure 18 for a picture of the fixture with
electrodes). The ability of the electrode holding tube to be able to slide off the body of
the fixture allowed the electrodes to be easily replaced in the event of breakage.
SolidWorks drawings of the electrode fixture can be found in the Appendix.

1

2

Figure 17 – Electrode Fixture
The electrode fixture used to make electrical property measurements.
The parts of the fixture are labeled 1 and 2.
The electrode fixture is made out of delrin. Delrin was chosen because it is nonconductive and would not interfere with the electrical measurements. Delrin is also
inexpensive which allowed for the costs associated with this thesis to be kept low. Other
benefits of using delrin include allowing the fixture to be non-corrosive and
biocompatible.
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Figure 18 - Electrode Fixture with Electrodes

A picture of the electrodes in the electrode fixture
Dimensions were chosen so that when the electrodes were inserted into the
fixture, they would be spaced 1 cm apart. This dimension was chosen to make it easy to
convert the measured values into units of Specific Resistivity (Ohm-m). Units of
Specific Resistivity will allow the electrical property measurements found in the
following experiments to be compared with data from the literature. Using units of Ohmm cancel out any effects from the size of the specimen tested, and will give values that
pertain to the inherent electrical properties of the material being tested. An electrode
spacing of 1 cm also allows the electrodes to be close enough to measure the tissue
analogues that are to be used. Too great of a distance between the electrodes could also
cause unnecessarily high resistance measurements, since more material would be taken
into account during the measurement, which could lead to measurement errors. All the
other dimensions were chosen to minimize the amount of material necessary to make the
fixture but still allow it to be usable.
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After preliminary tissue and equipment validation measurements were made, it
became apparent that it would be helpful if the electrode fixture was attached to another
fixture that would lower it and the electrodes down onto the sample and hold it steady.
This would allow the same pressure to be placed on the sample for each trial, and keep
the electrode fixture from moving during the measurement. A height gauge was modified
for this purpose. The electrode fixture was secured to the height gauge, which could then
be lowered onto the tissue sample (see Figure 19). Since the electrode fixture was not
secured in the vertical direction, the electrodes could only be pushed into the sample with
the weight of the electrode fixture. This allowed the pressure of the electrodes on the
sample to be consistent for each measurement.

Figure 19 – Height Gauge
The height gauge after it was modified
to hold the electrode fixture
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Measurement Electrodes
The electrodes that were used to make electrical properties measurements of the
skin analogues were made of a Silver-Chloride (AgCl) compound (see Figure 20). AgCl
electrodes are the most common type of electrode used when taking electrical
measurements of biologic tissue because the compound does not create a charge density
around the electrode. A charge density occurs when ions in the sample are attracted to the
electrode due to the alternating current. These ions accumulate at the electrode-tissue
interface, and interfere with the measurement. AgCl electrodes are also commonly used
to make biologic measurements because they themselves do not exhibit polarization
when a voltage is applied.

Figure 20 – AgCl Electrodes
The electrodes used to perform electrical property measurements
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The AgCl electrodes that were chosen for this thesis were Warner Instruments
pellet electrodes, model E255. This electrode was chosen because it had the smallest
diameter available (0.8 mm). A small diameter allows the electrodes to make more
accurate measurements because less tissue is under the electrode and a smaller area of
tissue is between the two electrodes (see Equation 1). The smaller measurement area
allows for the measurement resolution to be increased and also prevents too large of
values from being measured. The electrodes are also described as “suitable for probing
tissue” by the manufacturer.
Because the electrodes have a small diameter, they were brittle and subject to
bending and breaking. When this occurred, the broken electrodes were switched out for
new electrodes. This was facilitated by the fixture designed to allow the switching of
electrodes.
A bipolar, 2-electrode setup was used for several reasons. As it has been stated
earlier, and will be further explored later in the “Next Steps” section of this thesis, part of
the objective of this thesis was to investigate the possibility of using bipolar
radiofrequency tissue ablation to treat skin cancer. If the cancer is going to be treated
with a bipolar setup, it would be beneficial to also diagnose the cancer in the same
fashion. Bipolar electrodes also provide other benefits for making measurements. A
bipolar setup only measures the tissue directly in-between the electrodes. This leads to
more accurate measurements and thus a more accurate diagnosis because only the
suspected cancerous tissue in question is examined.
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National Instruments ELVIS
To perform the actual measurements of electrical properties for this thesis, a
National Instruments Educational Laboratory Virtual Instrumentation Suite (or ELVIS)
was used. ELVIS is a data acquisition device that uses a combination of hardware and
software to allow the user to perform experiments that require measurements,
automation, and control [26]. To perform the experiments in this thesis without ELVIS
would have required the additional purchase of a separate power generator, oscilloscope,
and function generator. Instead, ELVIS uses virtual equivalents of these built into the
software, with a bench-top breadboard to allow the physical experimental materials to
interface with the software. This allowed the costs of running these experiments to be
greatly reduced.
The data acquisition device that was used for this thesis was the Impedance
Analyzer. The NI ELVIS Impedance Analyzer can measure the specific impedance
characteristics, which is a combination of resistance and reactance, of the device or
material being tested. The NI ELVIS system accomplishes this by imputing an AC sine
wave current source from the CURRANT HI pin to “excite” the material. The resulting
sine wave is measured on the CURRANT HI and CURRANT LOW pins and then broken
down into: phase, magnitude, resistance, and reactance of the material [26]. A sample
output is shown in Figure 16. NI ELVIS system allows a researcher to easily investigate
the electrical properties of a sample by inserting the electrodes into the CURRANT HI
and CURRANT LOW pins, creating a Schwan electrode setup. All the researcher must
do is select the measurement frequency.
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The Impedance Analyzer allows for the user to select the frequency for the AC
sine wave currant source. A value of 10 kHz was chosen to perform these experiments
because it was the highest possible value that could be produced by the NI ELVIS
system. A high value was chosen because tissue ablation often uses signals in the 100s
kHz range (see the “Tissue Ablation” section for more), and it was believed to be helpful
to perform the measurements at a frequency similar to possible ablation frequencies. A
high frequency was also chosen because higher frequencies are better at preventing
charge densities from building up in the material and result in lower impedances in
biologic tissues.
For each measurement, the Impedance Analyzer was turned on, the bipolar
electrodes placed on the sample, and then the signal output would be allowed to settle.
This settling could take anywhere from 10-30 seconds. Once the output had resolved, the
resistance and reactance would be recorded, along with a screen shot of the graphical
output (see Figure 21 for an example of the graphical output) for archiving.
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Figure 21 – Sample ELVIS Output
An example output of the ELVIS impedance analyzer
Reactance and resistance are the two components that make up a material's
electrical impedance. Resistance is the material's opposition to current flow on the real
number line, and is measured in Ohms. Reactance is the material's opposition to current
flow on the imaginary number line, and is also measured in Ohms. Resistance and
reactance can be used to find a material's total impedance (also with units of Ohms) using
Equation 2:
Equation 2-Impedance as a Function of Resistance and Reactance:
I = (R2 + Xr2)1/2
Where:
I = Impedance

Xr = Reactance
R = Resistance
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Therefore, a material's impedance can be seen as the magnitude of the resistance
and reactance, separated by an angle, or phase shift. The capacitance of a material can be
found if the reactance and measurement frequency are known using Equation 3:
Equation 3-Capacitance as a Function of Frequency and Reactance:
C = -1 / (2 * pi * F * Xr)

Where:
C = Capacitance
Xr = Reactance
F = Frequency

Validation and Experimental Samples
The main purpose of this thesis is to investigate a new method of skin cancer
diagnosis. This method would involve measuring the electrical properties of the suspect
tumor, comparing it to known average values of healthy skin tissue and cancerous skin
tissue, and making a diagnosis based on the results of the comparison. In order to decide
if this is a viable diagnosing method, it must be first established that there is a measurable
difference between healthy skin and cancerous skin. This will be the main objective for
the experiments of this thesis: to build a database of the electrical properties of healthy
and cancerous tissue, and to determine if there is a statistical difference between the two
groups. To do this analysis, experiments were performed with the previously mentioned
fixture, electrodes, and data acquisition device on tissue samples to determine if a
difference between the electrical properties of the samples could be seen. The following
section will outline the different samples tested and the reasoning behind why there were
chosen. Some of the samples were tested to first validate the experimental methods and
NI ELVIS system, while other samples were tested for the purpose of creating the
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aforementioned database. To see the results of the experiments, please see the section
titled “Data.”

Elvis Validation
The purpose of the first experiments performed for this thesis was to validate the
ELVIS system. The author wanted to make sure that the values reported by the ELVIS
system were accurate over the range of impedance values expected to be seen with tissue.
This validation was performed by measuring various resistors and capacitors and
comparing the measured values to the stated values of the circuit elements. The circuit
elements were plugged directly into the CURRANT OUT and CURRANT IN pins (the
electrode fixture and electrodes were not used) on the ELVIS data acquisition device and
the impedance analyzer was used at a frequency of 10 kHz. The values of the resistors
tested were: 10, 100, 1,000, 10,000, 100,000, and 1M Ohms. Three different resistors for
each value were tested. The values for the capacitors tested were: 1E-5, 1E-6, 1E-7, 1E8, and 1E-9 Farads. Three different capacitors for each value were tested.

It should be

noted that all the circuit elements had a stated error of +/- 5% by the manufacturer.

Bipolar Electrode and Electrode Fixture Validation
The purpose of the next experiments that were preformed was to validate the
experimental setup of the silver-chloride bipolar electrodes, electrode fixture, and ELVIS
system. This validation experiment was also performed to ensure that the small size of
the AgCl electrodes would not skew the electrical property measurements. This
experiment was performed in a similar manner to the ELVIS validation experiments, by
measuring sets of resistors and capacitors, and comparing the measured values to the
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stated values of the circuit elements. To perform these tests, the electrodes and electrode
fixture were set up how they would be for a tissue sample test on the ELVIS data
acquisition system and then the circuit elements were connected to the electrodes. The
values and number of resistors and capacitors tested was the same for the previous
validation test.

Raw Chicken
After the experimental system had been validated, the next set of experiments
consisted of using the ELVIS data acquisition system, bipolar electrodes, and electrode
fixture to measure the electrical properties of different tissue sections of a raw chicken
thigh (see Figure 22). The different sections of the chicken thigh that were tested were
the skin, thigh meat, and fat. The purpose of testing different types of tissues was to
evaluate whether or not the experimental methods used could distinguish between
different tissue types by measuring the electrical properties. Granted, the physical and
visual differences between chicken skin, fat, and thigh meat are quite large, but if the
system can distinguish a difference between them by only examining their electrical
properties, it may be possible that it can also distinguish a difference between healthy and
cancerous skin tissue. For the testing of raw chicken thigh meat, skin, and fat, each type
of tissue was measured 10 times at 10 kHz. After a measurement of one type was taken,
the bipolar electrodes were moved to another area of the same tissue and the
measurement repeated, until all 10 measurements had been recorded.
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Figure 22 – Raw Chicken Measurements
An example of a measurement being taken for
raw chicken meat

Raw Chicken versus Cooked Chicken
After the raw chicken electrical property measurements had been made, the
chicken samples that were used were cooked in a convection oven for 35 minutes at 350
degrees Fahrenheit. The same measurements that were previously taken were repeated
and recorded. The purpose of cooking the chicken and retaking the measurements was
that since a major contributor to the electrical properties of a biologic tissue (and one of
the main differences between normal tissue and tumors) is the water content of the tissue,
cooking the tissue should remove a large proportion of the water, causing the electrical
property values to change. These values were compared to the values obtained from the
same tissue before the sample was cooked, to investigate if water content made a
difference in the electrical properties. This experiment allowed the researcher to validate
that the experiment setup of ELVIS data acquisition system, bipolar electrodes, and
electrode fixture could distinguish between the different sample types (raw fat vs. cooked
fat, raw skin vs. cooked skin, raw thigh meat vs. cooked thigh meat).
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Human Skin Analogues
The final set of experiments that were preformed for this thesis involved
measuring the electrical properties of several skin tissue cultures from MatTek, Corp (see
Figure 23). Two different sets of skin tissue cultures were tested: normal skin tissue
(EpiDermTM) and skin tissue with malignant melanoma integrated into the sample
(MelanomaTM). The purpose of testing two different sets of human skin cultures was to
compare the results of the electrical property measurements for each set. Since one set
contains malignant melanocytes while the other does not, if a statistical difference can be
found between the two sets, the objective of this thesis will have been met: that
melanoma skin cancer can be diagnosed by measuring the electrical properties of the
suspected tumor and comparing those values to known values of healthy skin and
cancerous skin tissue.

Figure 23 – Skin Analogue Measurements
An example of an electrical property
measurement for a skin tissue analogue
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EpiDermTM skin model cultures were obtained from MatTek Corp. to be used as a
human skin analogue for healthy, non-cancerous skin. EpiDermTM has many features that
make it ideal for this purpose. The cultures are made from normal human epithelial
keratinocytes and take the form of 3-D, highly dimensional tissue (see figure 24). The
cultures are metabolically active and have an in vivo-like lipid profile. The samples have
been cultured on specially prepared cell culture inserts. MatTek Corp. claims that
EpiDermTM closely parallels human skin ultra structurally, and exhibits in vivo-like
morphological and growth characteristics. EpiDermTM consists of organized granular,
spinosum, and basal tissue layers, similar to those found in vivo [27]. It is important to
note that the EpiDermTM samples have an even distribution of cells, which is visible in
the figure.

Stratum
Corneum

Stratum
Basale

Figure 24 - EpiDermTM Histology
A slide of an EpiDermTM sample showing the
different keratinocyte morphologies
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The electrical properties of nine EpiDermTM samples were measured, with each
sample measured four times at a 90 degree rotation from each other. A total of 36
individual tests were used to build the database for “normal skin tissue”.
MelanomaTM skin model cultures were obtained from MatTek Corp. to be used as
human skin analogues for cancerous skin. MelanomaTM has many features that make it
ideal for this purpose. The cultures contain human malignant melanoma cells embedded
in 3-D, highly differentiated and human-like structure (see figure 25). The normal tissue
that the melanoma is seeded in consists of human-derived epidermal keratinocytes and
normal dermal fibroblasts, closely resembling the EpiDermTM samples. These cells have
been cultured to form a multilayered, highly differentiated epidermis. The epidermis of
the cultures consists of organized granular, spinosum, and basal epidermal layers, similar
to those found in vivo. Structurally, the model closely parallels the progression of
melanoma in vivo. The cultures also have a dermal component that is composed of a
collagen matrix and human dermal fibroblasts [27]. It is important to note that unlike the
EpiDermTM samples, the MelanomaTM samples do not have a uniform distribution of
cells. The melanoma cells project down into the dermal layer of the sample, similar to
the progression of melanoma in vivo.
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Figure 25 - MelanomaTM Histology

A slide of a MelanomaTM sample showing the different
keratinocyte morphologies and melanoma cells
The electrical properties of six MelanomaTM samples were measured, with each
sample measured eight times at a 45 degree rotation from each other. A total of 48
individual tests were used to build the database for “cancerous skin tissue”.
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Data
After the validation and electrical property measurements were taken as outlined
in the “Validation and Experimental Samples” section, the data was entered into Minitab
for graphical and statistical analysis. It was used to create the charts, graphs, and
statistical hypothesis testing seen below. The following sections will present the data
gathered during the experiments. For a discussion of the data and analysis, please see the
“Conclusions” section.

ELVIS Validation Results
Table 3 contains the measured data for the ELVIS validation for resistance. The
face value of each resistor is listed, along with the measured value for each resistor. The
3rd column shows the percent error of the measured resistance to the listed value of
resistance. The final column shows whether the experimental error falls within the 5%
error that is reported by the manufacturer.
Table 3 – ELVIS Resistance Validation Data
Face Value of Resistor (Ohms)
10
10
10
100
100
100
1000
1000
1000
10000
10000
10000
100000
100000
100000
1000000
1000000
1000000

Measured Resistance (Ohms)
12.37
12.44
18.28
101.19
101.11
100.17
982.41
979.66
982.62
9840
9900
9810
97190
97720
97240
360630
354960
366200
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Experimental Error (%)
23.7
24.4
82.8
1.19
1.11
0.17
-1.759
-2.034
-1.738
-1.6
-1
-1.9
-2.81
-2.28
-2.76
-63.937
-64.504
-63.38

In Tolerance (Y/N)
N
N
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
N
N

Table 4 is the measured data for the ELVIS validation for capacitance. The face
value for each capacitor is listed, along with the measured reactance value for each
capacitor. The measured reactance values are then converted to capacitance using
Equation 3 so the measured values can be compared to the listed capacitance of each
capacitor. The 4th column shows the experimental error of the measured capacitance to
the listed capacitance. The final column shows whether the experimental error falls
within the 5% error that is reported by the manufacturer.
Table 4 – ELVIS Capacitance Validation Data
Face Value of
Capacitor (F)
1.00E-005
1.00E-005
1.00E-005
1.00E-006
1.00E-006
1.00E-006
1.00E-007
1.00E-007
1.00E-007
1.00E-008
1.00E-008
1.00E-008
1.00E-009
1.00E-009
1.00E-009

Measured Reactance
(Ohms)
1.27E-002
3.51E-002
5.39E-002
-14.09
-14.07
-13.78
-157.01
-165.36
-149.69
-1.60E+003
-1.59E+003
-1.57E+003
-1.53E+004
-1.57E+004
-1.62E+004

Calculated
Capacitance (F)
-1.25E-03
-4.53E-04
-2.95E-04
1.13E-06
1.13E-06
1.15E-06
1.01E-07
9.62E-08
1.06E-07
9.95E-09
1.00E-08
1.01E-08
1.04E-09
1.01E-09
9.82E-10

Experimental
Error (%)
-12631.89
-4634.33
-3054.97
12.96
13.12
15.50
1.37
-3.75
6.32
-0.53
0.10
1.37
4.09
1.37
-1.82

In Tolerance
(Y/N)
N
N
N
N
N
N
Y
Y
N
Y
Y
Y
Y
Y
Y

Below are two graphs (Scatterplot of ELVIS Resistance Validation and Scatterplot
of EVLIS Capacitance Validation) that show the measured ELVIS data for the resistors
and capacitors versus the theoretical listed values for both resistance and capacitance.
Where only one data point is visible is a result of a tight grouping of the data compared to
the scale of the graph.
Please note: the measured reactance of the 1.00E-005 capacitors was left out
because the ELVIS machine could not properly measure such a strong capacitor.
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Including this data on the graph would have made the graph difficult to read. However,
this data is still used in the analysis in the “Conclusions” section.
Scatterplot of ELVIS Resistance
Validation
Scatterplot of ELVIS Resistance Validation
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Scatterplot of ELVIS Capacitance Validation
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1.0000E-06

Bipolar Electrode and Electrode Fixture Validation Results
Table 5 contains the measured data for the electrode and fixture validation for
resistance. The listed value of each resistor is shown in column 1, along with the
measured value for each resistor in column 2. The 3rd column shows the experimental
error of the measured resistance to the listed resistance. The final column shows whether
the experimental error falls within the 5% error that is reported by the manufacturer.

Table 5 – Bipolar Electrode and Electrode Fixture Resistance Validation Data
Resistor Face Value (Ohms)

Measured Resistance (Ohms)

Experimental Error (%)

In Tolerance
(Y/N)

10

12.69

26.90

N

10

12.9

29.00

N

10

28.89

188.90

N

100

101.57

1.57

Y

100

101.36

1.36

Y

100

100.5

0.50

Y

1000

984.93

-1.51

Y

1000

983.07

-1.69

Y

1000

985.16

-1.48

Y

10000

9860

-1.40

Y

10000

9930

-0.70

Y

10000

9840

-1.60

Y

100000

95860

-4.14

Y

100000

96250

-3.75

Y

100000

95940

-4.06

Y

1000000

215290

-78.47

N

1000000

215560

-78.44

N

1000000

215790

-78.42

N

Table 8 is the measured data for the electrode and fixture validation for
capacitance. The listed value for each capacitor is shown in column 1, along with the
measured reactance for each capacitor in column 2. The measured reactance values are
then converted to capacitance so they can be compared to the listed capacitance of each
capacitor. The 4th column shows the experimental error of the measured capacitance to
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the listed capacitance. The final column shows whether the experimental percent error
falls within the 5% error that is reported by the manufacturer.

Table 6 – Bipolar Electrode and Electrode Fixture Capacitance Validation Data
Capacitor Face
Value (F)

Measured Reactance
(Ohms)

Calculated
Capacitance (F)

Experimental
Error (%)

In Tolerance
(Y/N)

1.00E-06

-13.96

1.14E-06

14.01

N

1.00E-06

-13.92

1.14E-06

14.34

N

1.00E-06

-13.65

1.17E-06

16.60

N

1.00E-07

-155.33

1.02E-07

2.46

Y

1.00E-07

-163.78

9.72E-08

-2.82

Y

1.00E-07

-148.08

1.07E-07

7.48

N

1.00E-08

-1580

1.01E-08

0.73

Y

1.00E-08

-1560

1.02E-08

2.02

Y

1.00E-08

-1550

1.03E-08

2.68

Y

1.00E-09

-14930

1.07E-09

6.60

N

1.00E-09

-15370

1.04E-09

3.50

Y

1.00E-09

-15810

1.01E-09

0.70

Y

Below are two graphs (Scatterplot of ELIVS and Electrode/Fixture Resistance
Validation and Scatterplot of ELVIS and Electrode/Fixture Capacitance Validation) that
show the measured ELVIS and electrode/fixture data versus theoretical face values for
both resistance and capacitance. Where only one data point is visible is a result of a tight
grouping of the data compared to the scale of the graph.
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Scatterplot of ELVIS and Electrode/Fixture Resistance
Validation
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Scatterplot of ELVIS and Electrode/Fixture Capacitance
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Raw Chicken Results
Below are the results from the electrical property measurements of raw
chicken using the bipolar electrodes, electrode fixture, and ELVIS as outlined in the
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“Validation and Experimental Samples” section. Table 7 contains the measured
resistance, reactance, and calculated capacitance of raw chicken skin. Table 8 contains
the measured resistance, reactance, and calculated capacitance of raw chicken thigh meat.
Table 9 contains the measured resistance, reactance, and calculated capacitance of raw
chicken fat.
Table 7 – Raw Chicken Skin Data
Raw Chicken Skin
Resistance (Ohms)

Raw Chicken Skin
Reactance (Ohms)

Calculated Raw Chicken Skin
Capacitance (F)

4280

-267.12

5.96E-08

3730

-244.66

6.51E-08

3110

-192.55

8.27E-08

3400

-251.03

6.34E-08

3630

-353.94

4.50E-08

4040

-435.22

3.66E-08

4970

-569.07

2.80E-08

4470

-366.45

4.34E-08

3480

-296.9

5.36E-08

3700

-428.73

3.71E-08

Table 8 – Raw Chicken Thigh Meat Data
Raw Chicken Thigh Meat
Resistance (Ohms)

Raw Chicken Thigh Meat
Reactance (Ohms)

Calculated Raw Chicken Thigh Meat
Capacitance (F)

2150

-335.22

4.75E-08

1660

-254.2

6.26E-08

1280

-195.71

8.13E-08

2120

-388.78

4.09E-08

1770

-320.58

4.96E-08

1550

-260.78

6.10E-08

1700

-345.63

4.60E-08

1550

-297.47

5.35E-08

1820

-392.4

4.06E-08

2110

-493.7

3.22E-08

64

Table 9 – Raw Chicken Fat Data
Raw Chicken Fat
Resistance (Ohms)

Raw Chicken Fat
Reactance (Ohms)

Calculated Raw Chicken Fat
Capacitance (F)

2920

-139.39

1.14E-07

1920

-92.53

1.72E-07

2130

-105.43

1.51E-07

2180

-104.61

1.52E-07

3720

-167.75

9.49E-08

3310

-231.6

6.87E-08

3190

-30.73

5.18E-07

2830

-146.11

1.09E-07

3690

-57.98

2.74E-07

3530

-12.13

1.31E-06

Table 10 contains the calculated impedance of each raw chicken tissue type using
Equation 2.
Table 10 – Raw Chicken Calculated Impedance
Calculated Raw Chicken Skin
Impedance (Ohms)

Calculated Raw Chicken Thigh Meat
Impedance (Ohms)

Calculated Raw Chicken Fat
Impedance (Ohms)

4288.33

2175.98

2923.33

3738.02

1679.35

1922.23

3115.95

1294.88

2132.61

3409.25

2155.35

2182.51

3647.21

1798.8

3723.78

4063.38

1571.78

3318.09

5002.47

1734.78

3190.15

4485

1578.29

2833.77

3492.64

1861.82

3690.46

3724.76

2166.99

3530.02

The following boxplots show the resistance, reactance, and impedance of each
raw chicken tissue compared to each other. Boxplots break data up into quartiles. The
two vertical lines show the 1st and 4th quartiles, while the shaded box shows the 2nd and
3rd quartiles. The horizontal line through each box shows the 50th percentile, or the mean
average. Boxplots that are on a different horizontal level with each other would suggest
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that different values are measured for each type of tissue, and thus a difference between
the electrical properties between the tissues.
The following boxplot, “Boxplot of Raw Chicken Skin vs. Meat vs. Fat
Resistance” shows the measured resistance data for raw chicken. The average resistance
measurements for skin, meat, and fat are: 3,881 Ohms, 1,771 Ohms, and 2,942 Ohms
respectively.
Boxplot of Raw Chicken Skin vs. Meat vs. Fat Resistance
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The following boxplot, “Boxplot of Raw Chicken Skin vs. Meat vs. Fat
Reactance” shows the measured reactance data for raw chicken. The average resistance
measurements for skin, meat, and fat are: -340.6 Ohms, -328.4 Ohms, and -108.8 Ohms
respectively.
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Boxplot of Raw Chicken Skin vs. Meat vs. Fat Reactance
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The following boxplot, “Boxplot of Raw Chicken Skin vs. Meat vs. Fat
Impedance” shows the calculated impedance data for raw chicken using Equation 2. The
average impedance values for skin, meat, and fat are: 3,897 Ohms, 1,801 Ohms, and
2,945 Ohms respectively.
Boxplot of Raw Chicken Skin vs. Meat vs. Fat Impedance
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fat impedance

The following scatterplot, “Scatterplot of Raw Chicken Skin vs. Meat vs. Fat
Electrical Properties” shows each measurement for each raw chicken tissue sample on the
same plot. Separate grouping of the measurements would suggest that there are
fundamental differences of the electrical properties between the tissue types.
Scatterplot of Raw Chicken Skin vs. Meat vs. Fat Electrical Properties
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A One-Way ANOVA (or Analysis of Variance) can be used to conclude whether
data from two or more sets are statistically different from each other. ANOVA returns a
test statistic which can be used to reject or accept a null hypothesis.
A One-Way ANOVA analysis was performed with Minitab on the raw chicken
impedance data. If by using the ANOVA analysis we can conclude that the tissues had
statistically different electrical properties, we can conclude that the experimental setup
was successful in detecting the different electrical properties of the tissues. We may also
conclude that different types of tissues have statistically different electrical properties.
The Minitab output, along with the ANOVA p-value, is shown below. A discussion about
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what conclusions can be reached, if any, from this output will be discussed in the
“Conclusions” section.
One-way ANOVA: Skin Impedance (, Thigh Meat Imped, Fat Impedance (O
Source
Factor
Error
Total

DF
2
27
29

S = 532.7

SS
22003739
7662734
29666472

MS
11001869
283805

R-Sq = 74.17%

Level
Skin Impedance (Ohms)
Thigh Meat Impedance (Oh
Fat Impedance (Ohms)

F
38.77

P
0.000

R-Sq(adj) = 72.26%

N
10
10
10

Mean
3896.7
1801.8
2944.7

StDev
565.4
294.6
667.0

Individual 95% CIs For Mean Based on
Pooled StDev
Level
---------+---------+---------+---------+
Skin Impedance (Ohms)
(----*----)
Thigh Meat Impedance (Oh (----*----)
Fat Impedance (Ohms)
(----*----)
---------+---------+---------+---------+
2100
2800
3500
4200
Pooled StDev = 532.7

Cooked Chicken Results
Below are the results from the electrical property measurements of cooked
chicken using the bipolar electrodes, electrode fixture, and ELVIS as outlined in the
“Validation and Experimental Samples” section. Table 11 contains the measured
resistance, reactance, and calculated capacitance of cooked chicken skin. Table 12
contains the measured resistance, reactance, and calculated capacitance of cooked
chicken thigh meat. Table 13 contains the measured resistance, reactance, and calculated
capacitance of cooked chicken fat.
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Table 11 – Cooked Chicken Skin Data
Cooked Chicken Skin
Resistance (Ohms)

Cooked Chicken Skin
Reactance (Ohms)

Calculated Cooked Chicken Skin
Capacitance (F)

6480

-742.27

2.14E-08

6220

-665.59

2.39E-08

5950

-804.37

1.98E-08

9280

-848.65

1.88E-08

12140

-991.42

1.61E-08

12970

-2440

6.52E-09

9270

-1530

1.04E-08

6650

-1250

1.27E-08

11400

-2040

7.80E-09

3300

-468.88

3.39E-08

Table 12 – Cooked Chicken Thigh Meat Data
Cooked Chicken Thigh Meat
Resistance (Ohms)

Cooked Chicken Thigh Meat
Reactance (Ohms)

Calculated Cooked Chicken Thigh Meat
Capacitance (F)

2840

-670.08

2.38E-08

2580

-624.3

2.55E-08

2870

-771.73

2.06E-08

3280

-733.05

2.17E-08

2920

-764.47

2.08E-08

2650

-781.86

2.04E-08

2590

-715.52

2.22E-08

2220

-642.91

2.48E-08

2380

-821.99

1.94E-08

2540

-724.78

2.20E-08

Table 13 – Cooked Chicken Thigh Mean Data
Cooked Chicken Fat
Resistance (Ohms)

Cooked Chicken Fat
Reactance (Ohms)

Calculated Cooked Chicken Fat
Capacitance (F)

22190

-1770

8.99E-09

22220

-2310

6.89E-09

26340

-5050

3.15E-09

17010

-1690

9.42E-09

34620

-1440

1.11E-08

15930

-654.13

2.43E-08

27670

-2380

6.69E-09

32440

-513.76

3.10E-08

28640

-3040

5.24E-09

44280

-5390

2.95E-09
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Table 14 contains the calculated impedance of each cooked chicken tissue type
using Equation 2.
Table 14 – Cooked Chicken Calculated Impedance
Calculated Cooked Chicken Skin
Impedance (Ohms)

Calculated Cooked Chicken Meat
Impedance (Ohms)

Calculated Cooked Chicken Fat
Impedance (Ohms)

6522.37

2917.98

22260.48

6255.51

2654.46

22339.75

6004.12

2971.95

26819.73

9318.72

3360.92

17093.75

12180.42

3018.41

34649.94

13197.52

2762.93

15943.42

9395.41

2687.02

27772.17

6766.46

2311.22

32444.07

11581.09

2517.95

28800.89

3333.1

2641.38

44606.84

The following boxplots show the resistance, reactance, and impedance of each
cooked chicken tissue compared to each other. Boxplots that are on a different horizontal
level with each other would suggest that different values are measured from each type of
tissue, and thus a difference between the electrical properties between the tissues.
The following boxplot, “Boxplot of Cooked Chicken Skin vs. Meat vs. Fat
Resistance” shows the measured resistance data for cooked chicken. The average
resistance measurements for skin, meat, and fat are: 8,366 Ohms, 2,687 Ohms, and
27,134 Ohms respectively.

71

Boxplot of Cooked Chicken Skin vs. Meat vs. Fat Resistance
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The following boxplot, “Boxplot of Cooked Chicken Skin vs. Meat vs. Fat
Reactance” shows the measured resistance data for cooked chicken. The average
reactance measurements for skin, meat, and fat are: -1,178 Ohms, -725.1 Ohms, and
2,424 Ohms respectively.
Boxplot of Cooked Chicken Skin vs. Meat vs. Fat Reactance
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The following boxplot, “Boxplot of Cooked Chicken Skin vs. Meat vs. Fat
Impedance” shows the calculated impedance data for cooked chicken using Equation 2.
The average impedance values for skin, meat, and fat are: 8,455 Ohms, 2,784.4 Ohms,
and 27,273 Ohms respectively.
Boxplot of Cooked Chicken Skin vs. Meat vs. Fat Impedance
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The following scatterplot, “Scatterplot of Cooked Chicken Skin vs. Meat vs. Fat
Electrical Properties” show the measurements for each cooked chicken tissue sample on
the same plot. Separate grouping of the measurements would suggest that there are
fundamental differences of the electrical properties between the tissue types.
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Scatterplot of Cooked Chicken Skin vs. Meat vs. Fat Electrical Properties

Variable
cooked skin reactance * cooked skin resistance
cooked meat reactance * cooked meat resistance
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A One-Way ANOVA analysis was performed with Minitab on the cooked chicken
impedance data. If by using the ANOVA analysis we can conclude that the tissues had
statistically different electrical properties, we can conclude that the experimental setup
was successful in detecting the different electrical properties of the tissues. We may also
conclude that different types of tissues have statistically different electrical properties.
The Minitab output, along with the ANOVA p-value, is shown below. A discussion about
what conclusions can be reached, if any, from this output will be discussed in the
“Conclusions” section.
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One-way ANOVA: cooked skin impe, cooked meat impe, cooked fat imped
Source
Factor
Error
Total
S = 5299

DF
2
27
29

SS
3286532094
758069173
4044601267

MS
1643266047
28076636

R-Sq = 81.26%

F
58.53

P
0.000

R-Sq(adj) = 79.87%

Level
cooked skin impedance
cooked meat impedance
cooked fat impedance

N
10
10
10

Mean
8455
2784
27273

StDev
3187
295
8601

Level
cooked skin impedance
cooked meat impedance
cooked fat impedance

Individual 95% CIs For Mean Based on
Pooled StDev
-+---------+---------+---------+-------(----*---)
(---*----)
(---*---)
-+---------+---------+---------+-------0
8000
16000
24000

Pooled StDev = 5299

Raw Chicken versus Cooked Chicken Results
The following scatterplots compare the electrical properties for each chicken
tissue type between raw and cooked chicken. Again, separate groupings would suggest
that the experimental system was able to determine a difference between the electrical
properties that occurs when a biological tissue is cooked and the water content is
lowered.
The following scatterplot, “Scatterplot of Chicken Skin Raw vs. Cooked
Electrical Properties” shows the measured reactance and resistance of raw and cooked
chicken skin on the same graph.
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Scatterplot of Chicken Skin Raw vs. Cooked Electrical Properties

Variable
chicken skin reactance * chicken skin resistance
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The following scatterplot, “Scatterplot of Chicken Meat Raw vs. Cooked
Electrical Properties” shows the measured reactance and resistance of raw and cooked
chicken meat on the same graph.
Scatterplot of Chicken Meat Raw vs. Cooked Electrical Properties
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The following scatterplot, “Scatterplot of Chicken Fat Raw vs. Cooked Electrical
Properties” shows the measured reactance and resistance of raw and cooked chicken fat
on the same graph.
Scatterplot of Chicken Fat Raw vs. Cooked Electrical Properties
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T-tests were performed using Minitab to compare the differences in raw and
cooked chicken impedance results for each tissue type (skin, meat, and fat). T-tests are
used to conclude whether or not two groups of data are statistically different from each
other. T-tests are the equivalent of an ANOVA when data from only two set are being
compared. If by using a T-test we can conclude that each group of tissue (raw vs.
cooked) is statistically different from each other, we can conclude that the experimental
setup was successful in detecting the difference in electrical properties between the
tissues based on water content. We may also conclude that different types of tissues have
statistically different electrical properties. The Minitab output for each comparison,
along with the T-test p-value, is shown below. A discussion about what conclusions can
be reached, if any, from this output will be discussed in the “Conclusions” section.
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Two-Sample T-Test and CI: skin impedance, cooked skin impedance
Two-sample T for skin impedance vs cooked skin impedance

skin impedance
cooked skin impedance

N
10
10

Mean
3897
8455

StDev
565
3187

SE Mean
179
1008

Difference = mu (skin impedance) - mu (cooked skin impedance)
Estimate for difference: -4559
95% CI for difference: (-6875, -2243)
T-Test of difference = 0 (vs not =): T-Value = -4.45 P-Value = 0.002
= 9

DF

Two-Sample T-Test and CI: thigh meat impedance, cooked meat impedance
Two-sample T for thigh meat impedance vs cooked meat impedance

thigh meat impedance
cooked meat impedance

N
10
10

Mean
1802
2784

StDev
295
295

SE
Mean
93
93

Difference = mu (thigh meat impedance) - mu (cooked meat impedance)
Estimate for difference: -983
95% CI for difference: (-1261, -705)
T-Test of difference = 0 (vs not =): T-Value = -7.45 P-Value = 0.000
= 17

DF

Two-Sample T-Test and CI: fat impedance, cooked fat impedance
Two-sample T for fat impedance vs cooked fat impedance

fat impedance
cooked fat impedance

N
10
10

Mean
2945
27273

StDev
667
8601

SE Mean
211
2720

Difference = mu (fat impedance) - mu (cooked fat impedance)
Estimate for difference: -24328
95% CI for difference: (-30500, -18157)
T-Test of difference = 0 (vs not =): T-Value = -8.92 P-Value = 0.000
= 9

Human Skin Analogue Results
Table 15 contains the results from the electrical property measurements of
EpiDermTM tissue sample from MatTek Corp. using the bipolar electrodes, electrode
fixture, and ELVIS as outlined in the “Validation and Experimental Samples” section.
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DF

Table 15 – EpiDermTM Data
Tissue Sample

Resistance
(Ohms)

Reactance
(Ohms)

Calculated Impedance
(Ohms)

A

14350

-776.63

14371.00

A

15030

-939.91

15059.36

A

45330

-6460

45788.00

A

30770

-2370

30861.14

B

1920

-126.9

1924.19

B

2680

-123.05

2682.82

B

4440

-239.66

4446.46

B

6670

-668.26

6703.39

C

9640

-655.55

9662.26

C

13340

-2300

13536.82

C

7820

-359.14

7828.24

C

Not available

Not available

D

5900

-460.65

5917.96

D

6030

-449.12

6046.70

D

6210

-362.41

6220.57

D

6060

-423.76

6074.80

E

1500

-93.05

1502.88

E

1120

-109.88

1125.38

E

2140

-231.09

2152.44

E

1810

-168.81

1817.86

F

21540

-1610

21600.09

F

8820

-544.96

8836.82

F

12680

-651.23

12696.71

F

16790

-906.72

16814.47

G

1790

-123.77

1794.27

G

2110

-100.53

2112.39

G

2160

-93.26

2162.01

G

2150

-87.05

2151.76

H

2990

-124.27

2992.58

H

2340

-105.57

2342.38

H

2500

-109.27

2502.39

H

2210

-96.3

2212.10

I

2470

-114.54

2472.65

I

2390

-131.1

2393.59

I

2170

-118.93

2173.26

I

2180

-118.54

2183.22
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Not available

Below is the scatterplot, “Scatterplot of EpiDermTM Electrical Properties” that
shows the measured electrical properties of the EpiDermTM samples.
Scatterplot of EpiDermTM Electrical Properties
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Below is the Boxplot, “Boxplot of EpiDermTM Impedance” that shows the
calculated impedance values for each EpiDermTM sample.
Boxplot of EpiDermTM Impedance
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As one can see, there appear to be some outliers in the data that are skewing the
results. These data points (specifically samples: A, C, and F) have such a greater
variance and average than the other samples, it can be assumed that errors occurred
during the measurement of these samples. These samples have averages that are more
than two standard deviations from the mean of the rest of the data. These errors could
have be a result of the individual tissue samples drying out before they could be
measured. Since the samples were used in previous, unrelated experiments before given
to the author, it is rational to assume that they had been compromised. To stop these
outliers from skewing the data and following analysis, they will be removed from the
normal tissue dataset. The modified EpiDermTM data that will be used for the remainder
of this thesis is presented below in Table 16.
Table 16 – EpiDermTM Data W/O Outliers
Tissue Sample
W/O Outliers (Ohms)
B
B
B
B
D
D
D
D
E
E
E
E
G
G
G
G
H
H
H
H
I
I
I
I

Resistance
W/O Outliers (Ohms)
1920
2680
4440
6670
5900
6030
6210
6060
1500
1120
2140
1810
1790
2110
2160
2150
2990
2340
2500
2210
2470
2390
2170
2180

Reactance
W/O Outliers (Ohms)
-126.9
-123.05
-239.66
-668.26
-460.65
-449.12
-362.41
-423.76
-93.05
-109.88
-231.09
-168.81
-123.77
-100.53
-93.26
-87.05
-124.27
-105.57
-109.27
-96.3
-114.54
-131.1
-118.93
-118.54
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Calculated Impedance
W/O Outliers (Ohms)
1924.189079
2682.823383
4446.463417
6703.392531
5917.955595
6046.702306
6220.565972
6074.798148
1502.88333
1125.377099
2152.441077
1817.855004
1794.273951
2112.393496
2162.012356
2151.761535
2992.581333
2342.380205
2502.386847
2212.097125
2472.654325
2393.59295
2173.256622
2183.220495

Below is the scatterplot, “Scatterplot of EpiDermTM W/O Outliers Electrical
Properties” that shows the resistance and reactance of the EpiDermTM samples with the
outliers removed.
Scatterplot of EpiDermTM W/O Outliers Electrical Properties
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Below is the boxplot, “Boxplot of EpiDermTM W/O Outliers Impedance” that
shows the calculated impedance values of the EpiDermTM samples with the outliers
removed.
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Boxplot of EpiDermTM W/O Outliers Impedance
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Please note: from this point on, the EpiDermTM data will no longer be referred to
with the qualifier “W/O outliers.”
Below in Table 17 are the results from the electrical property measurements of
MelanomaTM tissue samples from MatTek Corp. using the bipolar electrodes, electrode
fixture, and ELVIS as outlined in the “Validation and Experimental Samples” section.
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Table 17 – MelanomaTM Data
Tissue Sample
Mel 1
Mel 1
Mel 1
Mel 1
Mel 1
Mel 1
Mel 1
Mel 1
Mel 2
Mel 2
Mel 2
Mel 2
Mel 2
Mel 2
Mel 2
Mel 2
Mel 3
Mel 3
Mel 3
Mel 3
Mel 3
Mel 3
Mel 3
Mel 3
Mel 4
Mel 4
Mel 4
Mel 4
Mel 4
Mel 4
Mel 4
Mel 4
Mel 5
Mel 5
Mel 5
Mel 5
Mel 5
Mel 5
Mel 5
Mel 5
Mel 6
Mel 6
Mel 6
Mel 6
Mel 6
Mel 6
Mel 6
Mel 6

Resistance (Ohms)
21600
33480
25360
29890
28120
4710
6390
24840
36340
4230
4990
5840
5400
5910
4580
4200
26760
32940
37160
32750
37480
34780
35610
32520
767.78
887.54
941.05
1020
1190
1210
1340
1630
1190
1280
1460
1320
1350
1310
1370
1450
5040
4770
11930
11180
11410
5920
5560
5080

Reactance (Ohms)
-5810
-8800
-9390
-6940
-9480
-455.12
-1030
-10270
-14300
-303.68
-776.39
-754.28
-597.93
-926.34
-485.33
-352.69
-6290
-7010
-10810
-7360
-9140
-9020
-6690
-4330
-25.25
-27.46
-36.56
-35.98
-39
-46.54
-61.87
-102.43
-86.14
-95.35
-121.03
-100.92
-100.07
-104.23
-113.21
-126.97
-659.75
-580.54
-3830
-4180
-4580
-961.16
-858.22
-742.57
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Calculated Impedance (Ohms)
22367.75
34617.20
27042.59
30685.11
29674.99
4731.94
6472.48
26879.33
39052.34
4240.89
5050.04
5888.51
5433.00
5982.16
4605.64
4214.78
27489.30
33677.64
38700.41
33566.83
38578.36
35930.61
36232.97
32807.00
768.20
887.96
941.76
1020.63
1190.64
1210.89
1341.43
1633.22
1193.11
1283.55
1465.01
1323.85
1353.70
1314.14
1374.67
1455.55
5083.00
4805.20
12529.72
11935.86
12294.90
5997.52
5625.85
5133.99

Below is the scatterplot, “Scatterplot of MelanomaTM Electrical Properties” that
shows the measured electrical properties of the MelanomaTM samples.
Scatterplot of MelanomaTM Electrical Properties
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Below is the Boxplot, “Boxplot of EpiDermTM Impedance” that shows the
calculated impedance values for each EpiDermTM sample.
Boxplot of MelanomaTM Impedance
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Comparison of MelanomaTM and EpiDermTM
For the following graphs and analysis, the data recorded from the measurement of
MelanomaTM and EpiDermTM were added to the same Minitab file. This allowed
comparisons between the two sets of data. Comparing the EpiDermTM and MelanomaTM
data is the primary test performed for this thesis. A statistical difference between the two
sets of data would suggest that melanoma tissue can be distinguished from normal tissue.
Below is the scatterplot, “Scatterplot of EpiDermTM and MelanomaTM Electrical
Properties” which shows the measured resistance and reactance values of the two
different tissue types on the same graph.
Scatterplot of EpiDermTM and MelanomaTM Electrical Properties
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Below is the boxplot, “Boxplot of EpiDermTM and MelanomaTM Impedance”
which shows the measured calculated impedance values of the two different tissue types
on the same graph. The average impedance for EpiDermTM and MelanomaTM are: 3,088
Ohms and 12,856 Ohms respectively.
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Boxplot of EpiDermTM and MelanomaTM Impedance
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A One-Way ANOVA analysis was performed with Minitab on the EpiDermTM and
MelanomaTM data. If by using the ANOVA analysis we can conclude that the tissues had
statistically different electrical properties, we can conclude that the experimental setup
was successful in detecting the different electrical properties of the tissues. We may also
conclude that different types of tissues have statistically different electrical properties.
The Minitab output, along with the ANOVA p-value, is shown below. A discussion about
what conclusions can be reached, if any, from this output will be discussed in the
“Conclusions” section.
One-way ANOVA: Impedance (Ohms) versus Sample
Source
Sample
Error
Total

DF
1
70
71

S = 11454

Level
EpiDerm
Melanoma

SS
1526660835
9184007210
10710668045

MS
1526660835
131200103

R-Sq = 14.25%

N
24
48

Mean
3088
12856

StDev
1736
13926

F
11.64

P
0.001

R-Sq(adj) = 13.03%
Individual 95% CIs For Mean Based on
Pooled StDev
---+---------+---------+---------+-----(--------*---------)
(------*-----)
---+---------+---------+---------+-----0
5000
10000
15000

Pooled StDev = 11454

87

Conclusions
The following sections will discuss the data that was gathered from the
experiments presented earlier in Table 3 through Table 17. When possible, the author
will come to a conclusion about what the data means in relation to the purpose of the
experiment and the objective of this thesis: to build a database of the electrical properties
of healthy and cancerous tissue, and determine if there are statistical differences between
the two types.

ELVIS Validation Discussion
The resistance and capacitance data gathered during the validation of the ELVIS
data acquisition system was presented in Tables 3 and 4. It is important that ELVIS
accurately and precisely measured resistance and capacitance over a range of values that
is possible with biologic tissues, since the system would be later used to measure chicken
tissue and human skin analogues.
From the data in Table 3, ELVIS accurately measured the resistance of the
resistors tested (within a 5% margin of error that was reported by the manufactures)
between the values of 100 to 100k Ohms. If the measured values of resistance of the
different tissue values fell within this range, we can conclude that the ELVIS system can
accurately measure resistance. The measured resistance values for raw chicken fell
between 1k and 5k Ohms, the measured resistance values of cooked chicken fell between
2k and 50k Ohms, and measured resistance values of the EpiDermTM and MelanomaTM
tissue analogues from MatTek Corp. fell between 1k and 40k Ohms. Since all the
measured tissue resistance values fell within the accurate range for ELVIS, we can be
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confident in concluding that the ELVIS system accurately reported the resistance
measurements that were inputted during these experiments.
Looking at the ELVIS validation data for capacitance in Table 4, one can see the
ELVIS system accurately measured the reactance of the capacitors tested (within a 5%
margin of error that was reported by the manufacturers) approximately between the
values of -100 and -16k Ohms (remember reactance is on the imaginary plane for
impedance, and a negative value for reactance converts to a positive value of capacitance.
See Equation 3). If the measured values of reactance of the different tissue values fell
within this range, we can conclude that the ELVIS system can accurately measure
reactance, and therefore capacitance. The measured reactance values for raw chicken fell
between -12 and -600 Ohms (with only 2 measurements out of 30 outside of the
acceptable range), the measured reactance values of cooked chicken fell between -600
and -5.5k Ohms, and the measured reactance values of the EpiDermTM and MelanomaTM
tissue analogues from MatTek Corp. fell between -100 and -14k Ohms (with only 3
measurements out of 60 outside the acceptable range for the entire dataset). Since most
of the measured tissue reactance values fell within the accurate range for the ELVIS
system, one can be confident in concluding that ELVIS accurately reported the reactance
measurements that were inputted during these experiments.
Since the possible measured values of resistance and reactance both fall in the
range of what is accurately measured by the ELVIS data acquisition system, one can
conclude that conclusions made about impedance (which is a combination of resistance
and reactance. See Equation 1) may be made from the data gathered using ELVIS and
that the data is valid.
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Bipolar Electrode and Electrode Fixture Validation Discussion
The resistance and capacitance data gathered during the validation of the bipolar
electrodes and electrode fixture was presented in Tables 5 and 6. It is important that the
bipolar electrodes and electrode fixture did not cause the measured electrical properties to
be skewed. If the bipolar electrode and electrode fixture did not affect the electrical
properties measured by ELVIS, the resistance and capacitance values reported by ELVIS
should be similar to the listed values of the resistors and capacitors used during the
ELVIS validation.
From the bipolar electrode and electrode fixture validation data presented in Table
5, ELVIS accurately measured the resistance of resistors (within a 5% margin of error
that was reported by the manufactures) between the values of 100 to 100k Ohms (note
that this is the same range for the ELVIS validation above). Since the addition of using
the bipolar electrodes and electrode fixture did not affect the range of resistance values
that the ELVIS system accurately reported, one can conclude that the bipolar electrodes
and electrode fixture did not significantly affect the resistance measurements.
From the bipolar electrode and electrode fixture validation data presented in Table
6, ELVIS accurately measured the reactance of capacitors (within a 5% margin of error
that was reported by the manufactures) between the values of approximately -100 and 1.6k Ohms (note that this is the same range for the ELVIS validation above). Since the
addition of using the bipolar electrodes and electrode fixture did not affect the range of
reactance values that the ELVIS system accurately reported, one can conclude that the
bipolar electrodes and electrode fixture did not significantly affect the reactance
measurements.
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Since the bipolar electrodes and electrode fixture did not affect the range of
accurate values of resistance and reactance that is measured by the ELVIS data
acquisition system, one can conclude that conclusions about impedance may be made
from the data gathered using ELVIS and that the data is valid.

Raw Chicken Discussion
The resistance and reactance data for the raw chicken experiments was presented
in Tables 7 through 10. The purpose of these measurements was to do a preliminary
investigation of whether or not the experimental setup could distinguish different raw
chicken tissues types based only on their electrical properties. If the system was able to
measure differences in the electrical properties of the different raw chicken tissue types
(skin, meat, and fat), separate groupings of the resistance and reactance measurements
should be visible, and there should be a statistical difference between the average
impedance for each group.
By visually examining the raw chicken data presented in the boxplots of raw
chicken and the stated mean averages in the “Data” section, one can see that the
resistance measurements for each tissue type are grouped separately. The average
resistance for each tissue type is different, and there is little overlap between the first and
third quartiles for each tissue type. Examining the boxplots for reactance, one can see
that the measured reactance for skin and meat are similar, but the reactance for fat is
different for both. When the impedance is calculated for the tissue types using Equation
2, resistance dominates and the impedance measurements are different for each tissue
sample. Examining the scatterplot of raw chicken data confirms that the electrical
properties are separately grouped.
91

Although the raw chicken data seems to show visually that the experimental setup
was able to find differences in the electrical properties of the three tissue types, it is
important to make sure that any difference is statistically significant, and not due to
random variations. To illustrate that the differences between the tissue types are
statistically significant, an ANOVA test was performed on the impedance values using
Minitab. The null hypothesis was chosen to be that there is no difference between the
mean impedance values and the alternative hypothesis was chosen to be that there is a
difference between at least one impedance mean. A significance value of 0.05 (meaning
there will be a 5% chance that the conclusion is wrong) was also chosen. Minitab
calculated a p-value of 0.000. Since 0.000 < 0.05, the null hypothesis is rejected and the
alternative hypothesis is concluded to be true.
It makes sense that the different raw chicken tissues have different impedance
values. Skin, muscle (or meat), and fat are all different structurally. The different
structures cause differences in the ability of ions to flow through the tissues. Also, some
tissues may have more ions and water available to transport an electrical current.
From this analysis, one can conclude that a statistical difference in the impedance
values between the raw chicken tissue types was recorded by the experimental setup and
the system was able to distinguish between tissues. This means that it is possible to
differentiate between tissues by examining their electrical properties.
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Cooked Chicken Discussion
The resistance and reactance data for the cooked chicken experiments was
presented in Tables 11 through 14. The purpose of these measurements was to do a
secondary investigation of whether or not the experimental setup could distinguish
different tissues types based only on their electrical properties, and also to create a
database of cooked tissue measurements to later compare with the raw chicken tissue data
(see “Raw Chicken versus Cooked Chicken Discussion” section). A secondary purpose
for cooking the chicken tissue was to simulate tissue with lower water content and
examine how this affects the electrical properties (this discussion will take place in the
next section, “Raw Chicken versus Cooked Chicken Discussion”). If the system was able
to measure differences in the electrical properties of the different cooked chicken tissue
types (skin, meat, and fat), separate groupings of the resistance and reactance
measurements should be visible, and there should be a statistical difference between the
average impedance for each group.
By visually examining the cooked chicken data presented in the boxplots for
cooked chicken, one can see that the resistance measurements for each tissue type are
grouped separately. The mean average resistance for each tissue type is different, and
there is no overlap between the first and third quartiles for each tissue type. Examining
the boxplots for reactance, one can see that the there is also a difference in the reactance
measurements for each tissue. When the impedance is calculated for the tissue types
using Equation 2, the impedance measurements are different for each tissue sample.
Examining the scatterplot of cooked chicken data confirms that the electrical properties
are grouped separately. It is interesting to note the different amounts of variance between
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the tissue types. The measurements for meat are tightly grouped and have a small
variance, the measurements for skin have a larger grouping, and the measurements for fat
have a very large grouping. This is probably due to the fact that the chicken meat cooked
the most uniformly, with an even distribution of water content throughout the tissue. The
skin and fat may not have cooked as uniformly, and contained areas of both high and low
water content.
Although the cooked chicken data seems to show visually that the experimental
setup was able to find differences in the electrical properties of the three tissue types, it is
important to make sure that any difference is statistically significant, and not due to
random variations. To show that the difference between tissue types is statistically
significant, an ANOVA test was performed on the impedance values using Minitab. The
null hypothesis was chosen to be that there is no difference between the mean impedance
values and the alternative hypothesis was chosen to be that there is a difference between
at least one impedance mean. A significance value of 0.05 (meaning there will be a 5%
chance that the conclusion is wrong) was also chosen. Minitab calculated a p-value of
0.000. Since 0.000 < 0.05, the null hypothesis is rejected and the alternative hypothesis
is concluded to be true.
From this analysis, one can conclude that a statistical difference in the impedance
values between the cooked chicken tissue types was recorded by the experimental setup
and the system was able to distinguish between tissues. This reinforces the previous
conclusion found during the raw chicken experiments that the experimental system was
able to distinguish the differences between tissues by examining only the electrical
properties of the tissue.
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Raw Chicken versus Cooked Chicken Discussion
The conclusion has been reached that the experimental setup was able to detect
differences in the electrical properties between different tissue types for both raw and
cooked chicken. To even further validate the fact that the experimental setup is able to
distinguish between tissues, the electrical property data for each tissue type will were
compared against each other for the raw and cooked chicken groups. If there is a
statistical difference, one can conclude that the setup was able to detect a difference in the
electrical properties of a tissue type based on the water content of the tissue (cooking the
tissue was done in order to remove water content), for the same type of tissue. This is
important because one of the primary differences between normal and cancerous tissue is
water content. If a diagnosis system based on electrical properties is going to be able to
detect the difference between normal and cancerous tissue, it will have to do so at least in
part by detecting a difference in water content.
Scatterplots for the electrical properties of each tissue type (for raw vs. cooked)
were presented above. By visually inspecting these graphs, one can see that there seems
to be separate groupings between raw and cooked tissue. This suggests that cooking
tissue causes a change in electrical properties due to a loss of water content in the tissue.
To show that there is a statistical difference between the raw and cooked chicken
impedance measurements for each tissue type, 2 Sample Student’s T-tests were
performed for each tissue type (2 Sample Student’s T-tests are the same as ANOVA tests
when comparing data from two samples). The null and alternative hypothesizes for each
grouping were chosen to be that there is no difference between the impedance means and
that there is a difference between the impedance means, respectively. A significance
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value of 0.05 (meaning there is only a 5% chance the conclusion is wrong) was chosen.
Minitab calculated the following p-values:
Table 18 – P Values
Test
P-Value
Raw vs. Cooked Skin
0.002
Raw vs. Cooked Meat
0.000
Raw vs. Cooked Fat
0.000
Since p-value < 0.05 for each test, each null hypothesis is rejected and each alternative
hypothesis is concluded to be true.
From the analysis, we can conclude there is a statistical difference of the electrical
properties between raw and cooked for each tissue type. Thus, we can conclude that the
experimental setup was able to detect differences in the electrical properties of a tissue
based on a change in water content. This further reinforces the conclusion that the
experimental setup is capable of detecting different tissue types by examining the
electrical properties of the tissues. Since these methods have worked to distinguish
different chicken tissue types, it may be possible that they can distinguish between
healthy and melanoma tissue.

EpiDermTM and MelanomaTM Discussion
Now that it has been shown that the experimental methods can detect differences
in tissue via measured electrical properties, what conclusions, if any, can one come to
about the human skin analogues data? The data gathered from the measurement of
EpiDermTM and MelanomaTM skin analogues was presented in Tables 15 through 17.
The purpose of these measurements was to determine if there is a statistical difference
between the two types. If there is, melanoma could be diagnosed in the future by
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measuring the electrical properties of the suspected tumor and comparing the results to
known ranges for healthy and cancerous skin.
By visually examining the scatterplots of resistance and reactance for EpiDermTM,
one can see that a large amount of the data points are grouped together, which suggest
reliable measurement. By visually examining the scatterplot and boxplot of the
MelanomaTM data, one can see that there is one group of data points that is tightly
grouped, while other data points are widely scattered. However, the data for each tissue
type is not meant to be examined on its own, they should be compared with each other.
When the data from EpiDermTM and MelanomaTM is put on the same scatterplot, one can
see that the tight grouping of the MelanomaTM data lies directly over the EpiDermTM data,
while the other grouping of MelanomaTM data is distinctly separate.
The question arises: why are there two separate groupings of the MelanomaTM
data, and what can be concluded from it? It has already been shown that the
measurements made by the ELVIS system, bipolar electrode, and electrode fixture
system are accurate, so it unlikely that the two groupings is due to measurement error.
Also, the large number of data points in the second MelanomaTM group (18 out of 48 total
data points) suggests that they are not a random occurrence, but rather an actual property
of the MelanomaTM samples. The main difference between the EpiDermTM and
MelanomaTM samples is that the MelanomaTM samples have melanoma cells (see the
“Validation and Experimental Tissues” section). It is possible that the melanoma was not
evenly distributed throughout the tissue samples. It is important to remember that the
tissue samples were rotated 45 degrees between each measurement, meaning a different
portion of the sample was recorded for each measurement. We can therefore confidently
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assume that the two distinct groupings of the MelanomaTM data was caused by the
electrodes sometimes measuring the normal tissue cells (which were the same as the
EpiDermTM samples), while at other times, the measurements were affected by the
melanoma cells. Now that the reason for the separate groupings of the MelanomaTM data
has been found, we can investigate if whether or not there is a statistical difference
between the EpiDermTM and MelanomaTM data.
To show that the difference between the EpiDermTM and MelanomaTM data is
statistically significant, an ANOVA test was performed on the impedance values using
Minitab. The null hypothesis was chosen to be that there is no difference between the
mean impedance values and the alternative hypothesis was chosen to be that there is a
difference between at least one impedance mean. A significance value of 0.05 (meaning
there will be a 5% chance that the conclusion is wrong) was also chosen. Minitab
calculated a p-value of 0.001. Since 0.001 < 0.05, the null hypothesis is rejected and the
alternative hypothesis is concluded to be true.
Using Minitab, it has been shown that there is a statistical difference between the
electrical properties of EpiDermTM and MelanomaTM data measured by the experimental
setup.
It is interesting to note that the resistance of the MelanomaTM samples where
cancer was detected the resistance was higher than the non-cancerous EpiDermTM
samples. This trend conflicts with the previous research done by Rigaud, B, et al (see the
“Electrical Properties of Skin” section). A possible explanation for this discrepancy is
that Rigaud performed his measurements and analysis on in vivo samples, whereas the
data collected for this thesis used in vitro samples.
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Final Conclusions
Using the gathered data and statistical analysis, the ELVIS data acquisition
system, AgCl bipolar electrodes, and electrode fixture have been validated and can be
used to reliably and accurately measure a material's electrical properties. Once the
validity of the experimental system was established, it was shown that the system could
detect significant differences in the electrical properties of different chicken tissue types.
It was shown that the system could also distinguish between the same tissue types when
the water content of one sample had been lowered. Finally, it was shown that the system
was able to distinguish differences between healthy and cancerous human skin tissue
analogues (when enough data points are taken so that the melanoma cells can be
measured). This means that it may be possible to diagnose melanoma by examination of
the electrical properties of the suspected tissue.
Now that it has been established that this type of system can distinguish between
normal and melanoma human skin analogues, the next step would be to test this system
on actual human skin samples, in vitro and then in vivo. Although the skin analogue data
provided clear differences between healthy and cancerous tissue, the differences for
actual human tissue may not be as great. Human skin is more complex (the dermis
contains nerve, blood vessels, and hair follicles), which may make the differences
between healthy and cancerous skin not as significant. However, this does not mean that
this method cannot be used to diagnose melanoma in vivo. As long as a database with a
large amount of data points is constructed, and enough data points of the suspected tumor
are taken, a statistical conclusion and diagnosis could still be made.
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The main goal of this thesis has been achieved; measurable differences in the
electrical properties of healthy and cancerous tissue have been recorded. A larger and
more complete database of healthy and cancerous tissue electrical properties can now be
established, and ranges for each tissue can be defined. Then, when a new measurement is
taken of a suspected tumor, the new data point can be compared to known values for
healthy and cancerous skin, and a diagnosis can be made.
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Next Steps: Diagnose and Treat Melanoma
The following sections are meant to be suggestions for future research and
experimentation to build on the work of this thesis. The author believes that the research
and data gathered for this thesis can be expanded and further investigated in the areas of
in-vivo cancer diagnosis and treatment. Since the diagnosis method of melanoma has
already been thoroughly examined, the following sections will focus on a novel
melanoma treatment method using radiofrequency tissue ablation. How such a device
might look and function will be discussed along with previous uses of radiofrequency
tissue ablation to treat cancer. The actual building of such a device is out of the scope for
this thesis, and will be reserved for a student at a later time. The purpose of the following
sections is to facilitate the next steps in the project. Further research, testing, and analysis
will need to be performed to continue this work.

Tissue Ablation
Introduction to Tissue Ablation
Since the one of goals of this thesis was to also investigate a method of skin
cancer treatment, radiofrequency tissue ablation is also investigated. Radiofrequency
tissue ablation uses an alternating current delivered to the target tissue to cause localized
heating of the tissue, which destroys a small volume of tissue without affecting other
surrounding structures beyond the treatment site [8]. Radiofrequency tissue ablation has
already been approved by the Food and Drug Admisnistration to treat some diseases such
as: liver cancer, kidney cancer, and lung tumors [1]. It is a preferred method of treatment
when a patient has co-morbidities or is not healthy enough for a more invasive treatment
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[28]. The following sections will provide information on: how radiofrequency tissue
ablation works, how it treats cancer, and also previous studies where radiofrequency
tissue ablation was used to treat liver and breast cancer. No previous uses of
radiofrequency tissue ablation to treat skin cancer were found in the literature.

What is Tissue Ablation?
Ablation is a term that is used to describe a procedure performed on the body to
destroy diseased or damaged structures [8]. Ablation can use heat, cold, or chemicals to
destroy tissue. This thesis will focus on radiofrequency tissue ablation, which uses the
direct application of electrical energy to a specific area in an attempt to cause thermal
injury and necrosis of the tissue [29].

How Radiofrequency Tissue Ablation Works
Radiofrequency tissue ablation creates heat in the targeted tissue by applying a
current to the tissue using electrodes. A generator creates a sinusoidal alternating
electrical current. The signal is generally in the 375 kHz to 500 kHz range, which
corresponds to the radiofrequency area of the electromagnetic spectrum. Most devices
that are currently used are monopolar. This means that a single electrode delivers the
alternating current signal to the tissue, and the signal returns to the generator through a
large grounding pad attached to the patient [29]. The current must travel through the
patient in order to complete the circuit. For devices that are bipolar, the current is
delivered to the tissue using an electrode and returns to the generator via a nearby
electrode.
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The treatment thermal heat is generated by friction. As the alternating current
oscillates back and forth between the electrode and grounding pad or other electrode,
charged ions and water molecules in the tissue in the current path vibrate back and forth
trying to follow the oscillation of the current. This ionic agitation leads to frictional
heating of the tissue [21]. Thermal injury of the tissue starts at 41 degrees Celsius, and
necrosis of cells occurs at 46 degrees Celsius [19]. Necrosis occurs because of the
denaturing of proteins vital to cell life and the loss of intracellular fluid [21].

Radiofrequency Tissue Ablation and Cancer
Radiofrequency tissue ablation is considered a reliable treatment method to
destroy some types of tumors because it can be used to cause cell necrosis in a small,
targeted area without affecting structures beyond the treatment site [1]. Radiofrequency
tissue ablation is considered safer than other ablation and treatment methods because
excess energy is absorbed in nearby tissues as simple heat [8]. Radiofrequency tissue
ablation treats cancer by killing the cancerous cells, which stops the ability of the cells to
replicate and spread. Radiofrequency tissue ablation also has the ability to kill healthy
cells. To stop the treatment from damaging healthy tissue, the treatment must be
monitored by the doctor or generator supplying the electrical current.
As the current is applied to a tumor, changes occur in the tissue. A decrease in the
ability of the soft tissue to conduct current occurs (see the previous “Practical
Observations” section). This leads to an increase in resistance seen by the generator.
This allows for the progress of the treatment to be monitored by monitoring the increase
in impedance [21].
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The two types of cancer that are often treated with radiofrequency tissue ablation
are liver and breast cancer. The following section will provide information on studies
conducted using radiofrequency tissue ablation on these cancers. Again, it is important to
note that no previous investigations into using radiofrequency tissue ablation for the
treatment of skin cancer were found.

Liver Cancer
In a 1998 study entitled “Ablation of Liver Tumors Using Percutaneous RF
Therapy,” Goldberg, Gazelle, et al. treated 29 patients who had a total of 44 hepatic
metastases. The purpose of the study was to determine what, if any, effects internally
cooled electrodes had on the volume of ablated tissue.
The researchers used a 500 kHz monopolar generator which not only provided
output energy but also measured output to the tissue, tissue impedance, and electrode tip
temperature. The current supplied by the generator was delivered to the liver metastases
with 18 gauge needles that were insulated except for the last 1-3 inches. The researchers'
experimental group of electrodes was internally cooled, where cooled perfusate was
circulated through the center of the electrode. The purpose of internally cooled
electrodes is to lower the temperature of the tissue at the tip of the electrode, in an
attempt to prevent burning of the tissue and to increase the volume of the ablated tissue.
The tip of the electrode was placed directly in the center of the tumors under the guidance
of ultrasound or CT scan.
After performing the treatment, the volume of ablated tissue was measured with a
CT scan. The volume of ablated tissue with traditional electrodes was limited to an
average of 1.6 cm diameter (see Figure 26 [30]). To create a larger volume with standard
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electrodes, the power to the tissue must be increased which results in tissue vaporization
and charring. Internally cooled electrodes however can ablate an average volume of 2.4
cm diameter. This is because since the electrode tip is cooled, more energy can be
deposited into the tissue [31]. The researchers also noticed that the volume of ablated
tissue is affected by the presence of large blood vessels in the vicinity of the treatment
site. The flow of blood acts as a heat sink and keeps the tissue from reaching the required
temperature for necrosis.

Figure 26 – Radiofrequency Ablation of the Liver
An example of liver tissue after treatment with
radiofrequency tissue ablation
Overall, the researchers were able to create volumes of necrosis of 1.5 to 4.5 cm
in diameter. Of the 29 patients treated, 94% were alive after 12 months. 50% of the
patients were still disease free after 12 months [30].
Other research by Solbiati, et al., also showed that radiofrequency tissue ablation
could be used to effectively treat liver cancer. Solbiati’s group used ultrasound imaging
techniques to guide the ablation electrode to the tumor [32].
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Breast Cancer
In the 1999 study entitled, “Radiofrequency Ablation of Breast Cancer,” Jeffrey,
Birdwell, et al, treated 5 women with breast cancer with radiofrequency energy right
before the resection of their tumors. They were attempting to determine if
radiofrequency tissue ablation is an acceptable treatment method for breast cancer.
The patients were treated with a 15 gauge multiple needle electrode for 30
minutes using a monopolar generator. The generator continuously monitored the power
applied to the tissue and the impedance seen by the electrodes. As the treatment
progressed, the impedance increased by a factor of ten and the power declined. The
researchers used this phenomenon to monitor the treatment. After the treatment, the
breasts were resected and the tumor was examined with an enzyme histochemical
analysis. The researchers noticed that the ablated tissue appeared the same to the naked
eye as the non-treated tissue. Under the histochemical analysis however, there was a
clear and defined line separating treated and non-treated tissue.
The researchers found evidence of cell death in all patients. The enzyme
histochemical analysis showed that the radiofrequency tissue ablation caused a volume of
necrosis with a diameter of 0.8 cm to 1.8 cm. From these results, the researchers were
able to conclude that radiofrequency tissue ablation of breast cancer results in cell death
[19].
Other research by Livraghi, et al., has also shown that radiofrequency tissue
ablation can be an effective treatment method for breast cancer [33].
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Skin Cancer and Radiofrequency Tissue Ablation
Currently, there are no published papers on the use of radiofrequency tissue
ablation to treat skin cancer. The author believes that this lack of previous treatment or
experimentation allows for a good opportunity to investigate the ability of radiofrequency
tissue ablation to treat skin cancer. Also, since radiofrequency tissue ablation has been
show to be effective for treating other type of cancer, there is reason to believe that it
would also be affective for treating skin cancer.

Bipolar versus Monopolar Electrodes
Tissue ablations that are currently used employ monopolar electrode systems. In a
monopolar electrode system, the alternating current from the generator is delivered to the
tissue by a single electrode (although this single electrode may have multiple leads). This
electrode is inserted through the skin and directly into the tissue and placed in the center
of the area that is to be treated. A grounding pad is placed on the thigh or back of the
patient. The therapeutic current disperses through the body before traveling to the
grounding pad to complete the electrical circuit. Since the current is delivered by one
electrode and spreads out from that electrode toward the grounding pad, the volume of
ablated tissue spreads out in a spherical fashion from the tip of the electrode. The longer
the current is applied, and the stronger the current, the larger the treatment volume.
Because the treatment volume of ablated tissue spreads in a spherical fashion and evenly
from the electrode, it is difficult to control what tissue is ablated besides by controlling
the size of the sphere.
Another type of tissue ablation method uses bipolar electrodes. In a bipolar
electrode system, the alternating current from the generator is delivered to the tissue by
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two closely spaced electrodes. The current alternates back and forth between the two
electrodes, instead of returning to grounding pad. Because the treatment current only
travels between two electrodes, only the tissue that is between the two electrodes is
ablated. This allows for much greater control over the ablated tissue. The volume of
ablated tissue depends on the amount of time the current is applied, the strength of the
current, and the configuration of the electrodes. Having this greater controls allows for
some structures to be treated, while other structures nearby are not treated.
The author believes that a bipolar electrode system should be used when treating
skin cancer with radiofrequency tissue ablation. Since melanoma lesions are relatively
small compared to other cancers (<4 mm diameter), bipolar electrodes would allow
greater control to ensure that only cancerous tissue is ablated and healthy tissue is not.
The following sections will go into greater depth on how this can be achieved.

How Tissue Ablation will be used to treat Skin Cancer
The following sections will outline how the author believes skin cancer can be
diagnosed and treated using a bipolar electrode system. These sections will include
information on: the difference between healthy and cancerous tissue and how this may
allow for a new method of cancer diagnosis, the electrode setup for such a device, and the
generator which will provide the treatment current. Please note that the following
sections are the opinions of the author, and will need to be validated by future
experimentation and research.
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Difference between Healthy and Cancerous Tissue
The differences between healthy tissue and cancerous tissue will play a large role
in the treatment of skin cancer using tissue ablation. It has been established by this thesis
(see the “Conclusions” section) that a difference between the impedance of normal tissue
and tissue containing melanoma cells is measurable. This fact will not only be important
in the diagnosis of a tumor, but it can also be used to facilitate the treatment of the tumor
using tissue ablation.
The data gathered for this thesis established the fact that melanoma tissue has
higher impedance than normal tissue. This fact can be used to diagnose and selectively
treat only tissue that matches the criteria of melanoma tissue. To do this, a “scan” of the
electrical impedance of the suspected tumor and the surrounded area can be made using a
device and electrode setup that is described below. A model of the scanned tissue can be
made in a computer and the area of cancer that needs treatment can be identified and
highlighted. Once the specific area of skin that needs treatment has been identified, the
tissue ablation treatment can progress. This can be done by selectively targeting the
highlighted cancerous areas. By only treating the cancerous skin, the surrounding healthy
tissue can be left alone. This will decrease scarring and healing times by minimizing the
treatment area.

Electrodes
The electrodes of the ablation device should be configured in a way that will
allow for the most control over the treatment area. Using a matrix of bipolar electrodes
will allow the system to analyze skin electrical properties and to map healthy and
cancerous tissue, and then apply the treatment electrical current only to the tissue that has
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been determined to be cancerous. A matrix of electrodes will allow the system to analyze
and treat a two dimensional area of tissue, instead of just a one dimensional area between
two point electrodes. Measurements of the skin's electrical properties will be measured
between each electrode, creating a “map” of the scanned tissue. The data will be
processed by a computer in the generator to determine the area of cancerous tissue. Once
this area has been determined, the generator can supply the electrical current to the
electrodes that touch the area of cancerous tissue. This will cause the cancerous tissue to
be ablated, while leaving tissue that has been determined to be healthy untreated.
The electrodes will be bipolar. This means that the electrical current for both
diagnosis and treatment will only travel from one electrode to another on the device.
There will not be a grounding pad. Bipolar electrodes will allow the treatment area to be
much more controlled because the treatment will only be applied between electrodes,
instead of spreading out from one electrode toward the grounding pad.
The density of electrodes used in the matrix will affect the resolution of the
system to both diagnose melanoma and the area that can be treated with radiofrequency
tissue ablation. In other words, the more electrodes per unit of area, the more accurate
the system will be able to build a model of the cancerous tissue and the better it will be at
applying a treatment current to only the identified tissue. The resolution should be small
enough to detect the smallest structures of skin cancer that can be detected through other
diagnosis techniques. The optimum electrode density will have to be investigated in later
experimentations.
The electrodes will be made of an AgCl compound. The reasons to use this
material are the same for why AgCl was used to gather the data earlier in this thesis.
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AgCl does not create a charge density around the electrode. A charge density occurs
when ions in the sample are attracted to the electrode due to the alternating current.
These ions accumulate and interfere with the measurements at the electrode-tissue
interface. AgCl electrodes also do not exhibit polarization when a voltage is applied.

Generator
To create the electrical signal that is needed to ablate the cancerous tissue, an
electrical generator is needed. The generator creates the electrical signal with the
appropriate voltage and frequency. The signal travels from the generator to the
electrodes via conductive wires.
Certain signal properties are often used for the ablation of human tissue. A
generator used for tissue ablation will have an output power of approximately 100 Watts
and a frequency of 490 kHz. This frequency corresponds to the radiofrequency section of
the electromagnetic spectrum. These power and frequency values correspond to
previous uses of Radiofrequency tissue ablation to treat other types of cancers.
Generators also have the ability to monitor the progress of the treatment while the
treatment signal is being applied. The generators accomplish this by monitoring the
impedance of the tissue at the treatment site. As the tissue is treated, the impedance
measured by the generator changes. When the impedance reaches a determined level that
corresponds to successful tissue ablation, the generator will automatically stop the
treatment. This capability allows treatment to be completed without the possibility of
over treating the tissue, which could lead to burning.
The generator can also contain the necessary computer hardware and software to
build the tissue model from the diagnosis data. This model is used to identify the
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cancerous tissue that needs treatment. Once this tissue has been identified, the computer
will program the generator to only apply the treatment current through the electrodes that
are over the melanoma.

Summary of Future Work
The fundamentals of radiofrequency tissue ablation, the previous uses of this
treatment method to treat cancer, and the possible look of a system that could be used to
treat melanoma have been outlined. A radiofrequency tissue ablation system could be
used alongside a diagnosis method that distinguishes between normal and cancerous skin
by examining the electrical properties of the tissue to treat melanoma. Such a system
would have the benefits of being less invasive to the patient and make more accurate
diagnoses over current diagnosis and treatment methods.
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Appendix
Drawing of electrode fixture, labeled as “Part 1” in “Electrode Fixture” section.
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Drawing of electrode fixture, labeled as “Part 2” in “Electrode Fixture” section.
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Assembly drawing of electrode fixture.
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